[English] 日本語

Yorodumi Papers

- Database of articles cited by EMDB/PDB/SASBDB data -

+
Search query

Keywords
Structure methods	All X-ray diffraction NMR electron microscopy small angle scattering neutron diffraction fiber diffraction powder diffraction infrared spectroscopy EPR fluorescence transfer theoretical model Hybrid
Author
Journal
IF	>30 >20 >10 >5 all

-
Structure paper

Title	PanDDA analysis group deposition
Journal, issue, pages	To Be Published
Publish date	May 15, 2017 (structure data deposition date)
Authors	Krojer, T. / Talon, R. / Fairhead, M. / Diaz Saez, L. / Bradley, A.R. / Aimon, A. / Collins, P. / Brandao-Neto, J. / Douangamath, A. / Ruda, G.F. ...Krojer, T. / Talon, R. / Fairhead, M. / Diaz Saez, L. / Bradley, A.R. / Aimon, A. / Collins, P. / Brandao-Neto, J. / Douangamath, A. / Ruda, G.F. / Szommer, T. / Srikannathasan, V. / Elkins, J. / Spencer, J. / London, N. / Nelson, A. / Brennan, P.E. / Huber, K. / Bountra, C. / Arrowsmith, C.H. / Edwards, A. / von Delft, F.
External links	Search PubMed
Methods	X-ray diffraction
Resolution	1.05 - 3.28 Å
Structure data	PDB-5q1j: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMSOA000341b Method: X-RAY DIFFRACTION / Resolution: 1.42 Å PDB-5q1k: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000074a Method: X-RAY DIFFRACTION / Resolution: 1.42 Å PDB-5q1l: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000073a Method: X-RAY DIFFRACTION / Resolution: 1.76 Å PDB-5q1m: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000740a Method: X-RAY DIFFRACTION / Resolution: 1.56 Å PDB-5q1n: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000295a Method: X-RAY DIFFRACTION / Resolution: 1.38 Å PDB-5q1o: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000478a Method: X-RAY DIFFRACTION / Resolution: 1.25 Å PDB-5q1p: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000299a Method: X-RAY DIFFRACTION / Resolution: 1.56 Å PDB-5q1q: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000294a Method: X-RAY DIFFRACTION / Resolution: 1.44 Å PDB-5q1r: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000291a Method: X-RAY DIFFRACTION / Resolution: 1.49 Å PDB-5q1s: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with BDOOA011525c Method: X-RAY DIFFRACTION / Resolution: 1.62 Å PDB-5q1t: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000492a Method: X-RAY DIFFRACTION / Resolution: 1.49 Å PDB-5q1u: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000351a Method: X-RAY DIFFRACTION / Resolution: 1.5 Å PDB-5q1v: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000166a Method: X-RAY DIFFRACTION / Resolution: 1.57 Å PDB-5q1w: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000546a Method: X-RAY DIFFRACTION / Resolution: 1.68 Å PDB-5q1x: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000085a Method: X-RAY DIFFRACTION / Resolution: 1.42 Å PDB-5q1y: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000032a Method: X-RAY DIFFRACTION / Resolution: 1.42 Å PDB-5q1z: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000150a Method: X-RAY DIFFRACTION / Resolution: 1.41 Å PDB-5q20: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000524a Method: X-RAY DIFFRACTION / Resolution: 1.76 Å PDB-5q22: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000728a Method: X-RAY DIFFRACTION / Resolution: 1.18 Å PDB-5q23: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000543a Method: X-RAY DIFFRACTION / Resolution: 1.32 Å PDB-5q24: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000676a Method: X-RAY DIFFRACTION / Resolution: 1.35 Å PDB-5q25: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000532a Method: X-RAY DIFFRACTION / Resolution: 1.43 Å PDB-5q26: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000710a Method: X-RAY DIFFRACTION / Resolution: 1.66 Å PDB-5q27: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000421a Method: X-RAY DIFFRACTION / Resolution: 1.83 Å PDB-5q28: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000186a Method: X-RAY DIFFRACTION / Resolution: 1.52 Å PDB-5q29: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000058a Method: X-RAY DIFFRACTION / Resolution: 1.46 Å PDB-5q2a: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 1) Method: X-RAY DIFFRACTION / Resolution: 1.5 Å PDB-5q2b: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 3) Method: X-RAY DIFFRACTION / Resolution: 1.33 Å PDB-5q2c: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 4) Method: X-RAY DIFFRACTION / Resolution: 1.53 Å PDB-5q2d: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 5) Method: X-RAY DIFFRACTION / Resolution: 1.4 Å PDB-5q2e: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 6) Method: X-RAY DIFFRACTION / Resolution: 1.5 Å PDB-5q2f: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 7) Method: X-RAY DIFFRACTION / Resolution: 1.47 Å PDB-5q2g: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 8) Method: X-RAY DIFFRACTION / Resolution: 1.49 Å PDB-5q2h: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 9) Method: X-RAY DIFFRACTION / Resolution: 1.72 Å PDB-5q2i: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 10) Method: X-RAY DIFFRACTION / Resolution: 2.33 Å PDB-5q2j: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 11) Method: X-RAY DIFFRACTION / Resolution: 1.3 Å PDB-5q2k: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 12) Method: X-RAY DIFFRACTION / Resolution: 1.65 Å PDB-5q2l: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 13) Method: X-RAY DIFFRACTION / Resolution: 1.42 Å PDB-5q2m: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 14) Method: X-RAY DIFFRACTION / Resolution: 1.28 Å PDB-5q2n: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 15) Method: X-RAY DIFFRACTION / Resolution: 1.38 Å PDB-5q2o: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 16) Method: X-RAY DIFFRACTION / Resolution: 1.75 Å PDB-5q2p: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 17) Method: X-RAY DIFFRACTION / Resolution: 1.55 Å PDB-5q2q: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 18) Method: X-RAY DIFFRACTION / Resolution: 1.44 Å PDB-5q2r: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 19) Method: X-RAY DIFFRACTION / Resolution: 1.37 Å PDB-5q2s: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 20) Method: X-RAY DIFFRACTION / Resolution: 1.52 Å PDB-5q2t: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 21) Method: X-RAY DIFFRACTION / Resolution: 1.52 Å PDB-5q2u: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 22) Method: X-RAY DIFFRACTION / Resolution: 1.37 Å PDB-5q2v: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 23) Method: X-RAY DIFFRACTION / Resolution: 1.58 Å PDB-5q2w: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 24) Method: X-RAY DIFFRACTION / Resolution: 1.53 Å PDB-5q2x: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 25) Method: X-RAY DIFFRACTION / Resolution: 1.5 Å PDB-5q2y: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 26) Method: X-RAY DIFFRACTION / Resolution: 1.61 Å PDB-5q2z: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 27) Method: X-RAY DIFFRACTION / Resolution: 1.55 Å PDB-5q30: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 28) Method: X-RAY DIFFRACTION / Resolution: 1.8 Å PDB-5q31: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 29) Method: X-RAY DIFFRACTION / Resolution: 1.55 Å PDB-5q32: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 30) Method: X-RAY DIFFRACTION / Resolution: 1.87 Å PDB-5q33: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 31) Method: X-RAY DIFFRACTION / Resolution: 1.37 Å PDB-5q34: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 32) Method: X-RAY DIFFRACTION / Resolution: 1.49 Å PDB-5q35: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 33) Method: X-RAY DIFFRACTION / Resolution: 1.47 Å PDB-5q36: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 34) Method: X-RAY DIFFRACTION / Resolution: 1.39 Å PDB-5q37: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 35) Method: X-RAY DIFFRACTION / Resolution: 1.5 Å PDB-5q38: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 36) Method: X-RAY DIFFRACTION / Resolution: 1.39 Å PDB-5q39: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 37) Method: X-RAY DIFFRACTION / Resolution: 1.7 Å PDB-5q3a: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 38) Method: X-RAY DIFFRACTION / Resolution: 1.48 Å PDB-5q3b: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 39) Method: X-RAY DIFFRACTION / Resolution: 2.52 Å PDB-5q3c: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 40) Method: X-RAY DIFFRACTION / Resolution: 1.41 Å PDB-5q3d: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 41) Method: X-RAY DIFFRACTION / Resolution: 1.71 Å PDB-5q3e: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 42) Method: X-RAY DIFFRACTION / Resolution: 1.49 Å PDB-5q3f: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 43) Method: X-RAY DIFFRACTION / Resolution: 1.39 Å PDB-5q3g: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 44) Method: X-RAY DIFFRACTION / Resolution: 1.29 Å PDB-5q3h: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 45) Method: X-RAY DIFFRACTION / Resolution: 1.56 Å PDB-5q3i: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 46) Method: X-RAY DIFFRACTION / Resolution: 1.53 Å PDB-5q3j: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 47) Method: X-RAY DIFFRACTION / Resolution: 1.44 Å PDB-5q3k: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 48) Method: X-RAY DIFFRACTION / Resolution: 1.39 Å PDB-5q3l: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 49) Method: X-RAY DIFFRACTION / Resolution: 1.61 Å PDB-5q3m: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 50) Method: X-RAY DIFFRACTION / Resolution: 1.34 Å PDB-5q3n: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 51) Method: X-RAY DIFFRACTION / Resolution: 1.62 Å PDB-5q3o: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 52) Method: X-RAY DIFFRACTION / Resolution: 1.6 Å PDB-5q3p: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 53) Method: X-RAY DIFFRACTION / Resolution: 1.44 Å PDB-5q3q: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 54) Method: X-RAY DIFFRACTION / Resolution: 1.39 Å PDB-5q3r: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 55) Method: X-RAY DIFFRACTION / Resolution: 1.5 Å PDB-5q3s: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 56) Method: X-RAY DIFFRACTION / Resolution: 1.72 Å PDB-5q3t: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 57) Method: X-RAY DIFFRACTION / Resolution: 1.52 Å PDB-5q3u: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 58) Method: X-RAY DIFFRACTION / Resolution: 1.49 Å PDB-5q3v: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 59) Method: X-RAY DIFFRACTION / Resolution: 1.52 Å PDB-5q3w: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 60) Method: X-RAY DIFFRACTION / Resolution: 1.5 Å PDB-5q3x: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 61) Method: X-RAY DIFFRACTION / Resolution: 1.38 Å PDB-5q3y: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 62) Method: X-RAY DIFFRACTION / Resolution: 1.45 Å PDB-5q3z: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 63) Method: X-RAY DIFFRACTION / Resolution: 1.84 Å PDB-5q40: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 64) Method: X-RAY DIFFRACTION / Resolution: 2.04 Å PDB-5q41: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 65) Method: X-RAY DIFFRACTION / Resolution: 1.95 Å PDB-5q42: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 66) Method: X-RAY DIFFRACTION / Resolution: 1.68 Å PDB-5q43: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 67) Method: X-RAY DIFFRACTION / Resolution: 1.47 Å PDB-5q44: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 69) Method: X-RAY DIFFRACTION / Resolution: 1.55 Å PDB-5q45: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 70) Method: X-RAY DIFFRACTION / Resolution: 1.64 Å PDB-5q46: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 71) Method: X-RAY DIFFRACTION / Resolution: 2.01 Å PDB-5q47: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 72) Method: X-RAY DIFFRACTION / Resolution: 1.38 Å PDB-5q48: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 73) Method: X-RAY DIFFRACTION / Resolution: 1.44 Å PDB-5q49: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 74) Method: X-RAY DIFFRACTION / Resolution: 1.38 Å PDB-5q4a: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 75) Method: X-RAY DIFFRACTION / Resolution: 1.83 Å PDB-5q4b: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 76) Method: X-RAY DIFFRACTION / Resolution: 1.6 Å PDB-5q4c: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 77) Method: X-RAY DIFFRACTION / Resolution: 2.73 Å PDB-5q4d: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 78) Method: X-RAY DIFFRACTION / Resolution: 1.8 Å PDB-5q4e: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 79) Method: X-RAY DIFFRACTION / Resolution: 1.39 Å PDB-5q4f: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 80) Method: X-RAY DIFFRACTION / Resolution: 1.97 Å PDB-5q4g: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 81) Method: X-RAY DIFFRACTION / Resolution: 1.75 Å PDB-5q4h: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 82) Method: X-RAY DIFFRACTION / Resolution: 1.53 Å PDB-5q4i: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 83) Method: X-RAY DIFFRACTION / Resolution: 1.55 Å PDB-5q4j: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 84) Method: X-RAY DIFFRACTION / Resolution: 1.55 Å PDB-5q4k: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 85) Method: X-RAY DIFFRACTION / Resolution: 1.47 Å PDB-5q4l: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 86) Method: X-RAY DIFFRACTION / Resolution: 1.6 Å PDB-5q4m: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 87) Method: X-RAY DIFFRACTION / Resolution: 1.6 Å PDB-5q4n: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 88) Method: X-RAY DIFFRACTION / Resolution: 1.71 Å PDB-5q4o: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 89) Method: X-RAY DIFFRACTION / Resolution: 1.83 Å PDB-5q4p: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 90) Method: X-RAY DIFFRACTION / Resolution: 1.4 Å PDB-5q4q: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 91) Method: X-RAY DIFFRACTION / Resolution: 1.42 Å PDB-5q4r: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 92) Method: X-RAY DIFFRACTION / Resolution: 2 Å PDB-5q4s: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 93) Method: X-RAY DIFFRACTION / Resolution: 1.72 Å PDB-5q4t: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 94) Method: X-RAY DIFFRACTION / Resolution: 1.77 Å PDB-5q4u: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 95) Method: X-RAY DIFFRACTION / Resolution: 2 Å PDB-5q4v: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 96) Method: X-RAY DIFFRACTION / Resolution: 1.59 Å PDB-5q4w: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 97) Method: X-RAY DIFFRACTION / Resolution: 1.8 Å PDB-5q4x: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 98) Method: X-RAY DIFFRACTION / Resolution: 1.66 Å PDB-5q4y: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 99) Method: X-RAY DIFFRACTION / Resolution: 1.69 Å PDB-5q4z: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 100) Method: X-RAY DIFFRACTION / Resolution: 1.6 Å PDB-5q50: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 101) Method: X-RAY DIFFRACTION / Resolution: 2 Å PDB-5q51: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 102) Method: X-RAY DIFFRACTION / Resolution: 1.34 Å PDB-5q52: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 103) Method: X-RAY DIFFRACTION / Resolution: 1.7 Å PDB-5q53: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 104) Method: X-RAY DIFFRACTION / Resolution: 1.55 Å PDB-5q54: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 105) Method: X-RAY DIFFRACTION / Resolution: 1.3 Å PDB-5q55: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 106) Method: X-RAY DIFFRACTION / Resolution: 1.39 Å PDB-5q56: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 107) Method: X-RAY DIFFRACTION / Resolution: 1.87 Å PDB-5q57: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 108) Method: X-RAY DIFFRACTION / Resolution: 1.65 Å PDB-5q58: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 109) Method: X-RAY DIFFRACTION / Resolution: 1.75 Å PDB-5q59: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 110) Method: X-RAY DIFFRACTION / Resolution: 1.86 Å PDB-5q5a: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 111) Method: X-RAY DIFFRACTION / Resolution: 2.26 Å PDB-5q5b: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 112) Method: X-RAY DIFFRACTION / Resolution: 1.58 Å PDB-5q5c: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 113) Method: X-RAY DIFFRACTION / Resolution: 1.38 Å PDB-5q5d: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 114) Method: X-RAY DIFFRACTION / Resolution: 1.71 Å PDB-5q5e: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 115) Method: X-RAY DIFFRACTION / Resolution: 1.49 Å PDB-5q5f: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 116) Method: X-RAY DIFFRACTION / Resolution: 1.47 Å PDB-5q5g: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 117) Method: X-RAY DIFFRACTION / Resolution: 2 Å PDB-5q5h: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 118) Method: X-RAY DIFFRACTION / Resolution: 1.36 Å PDB-5q5i: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 119) Method: X-RAY DIFFRACTION / Resolution: 1.65 Å PDB-5q5j: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 120) Method: X-RAY DIFFRACTION / Resolution: 2 Å PDB-5q5k: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 121) Method: X-RAY DIFFRACTION / Resolution: 2.81 Å PDB-5q5l: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 122) Method: X-RAY DIFFRACTION / Resolution: 2 Å PDB-5q5m: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 123) Method: X-RAY DIFFRACTION / Resolution: 1.57 Å PDB-5q5n: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 124) Method: X-RAY DIFFRACTION / Resolution: 2.42 Å PDB-5q5o: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 125) Method: X-RAY DIFFRACTION / Resolution: 2.07 Å PDB-5q5p: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 126) Method: X-RAY DIFFRACTION / Resolution: 1.58 Å PDB-5q5q: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 127) Method: X-RAY DIFFRACTION / Resolution: 1.45 Å PDB-5q5r: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 128) Method: X-RAY DIFFRACTION / Resolution: 1.39 Å PDB-5q5s: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 129) Method: X-RAY DIFFRACTION / Resolution: 1.7 Å PDB-5q5t: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 130) Method: X-RAY DIFFRACTION / Resolution: 1.8 Å PDB-5q5u: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 131) Method: X-RAY DIFFRACTION / Resolution: 1.88 Å PDB-5q5v: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 132) Method: X-RAY DIFFRACTION / Resolution: 1.86 Å PDB-5q5w: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 133) Method: X-RAY DIFFRACTION / Resolution: 1.42 Å PDB-5q5x: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 134) Method: X-RAY DIFFRACTION / Resolution: 1.5 Å PDB-5q5y: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 135) Method: X-RAY DIFFRACTION / Resolution: 1.82 Å PDB-5q5z: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 136) Method: X-RAY DIFFRACTION / Resolution: 1.48 Å PDB-5q60: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 137) Method: X-RAY DIFFRACTION / Resolution: 1.4 Å PDB-5q61: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 138) Method: X-RAY DIFFRACTION / Resolution: 1.71 Å PDB-5q62: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 139) Method: X-RAY DIFFRACTION / Resolution: 1.52 Å PDB-5q63: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 140) Method: X-RAY DIFFRACTION / Resolution: 1.82 Å PDB-5q64: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 141) Method: X-RAY DIFFRACTION / Resolution: 1.42 Å PDB-5q65: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 142) Method: X-RAY DIFFRACTION / Resolution: 1.78 Å PDB-5q66: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 143) Method: X-RAY DIFFRACTION / Resolution: 1.51 Å PDB-5q67: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 144) Method: X-RAY DIFFRACTION / Resolution: 1.65 Å PDB-5q68: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 145) Method: X-RAY DIFFRACTION / Resolution: 1.86 Å PDB-5q69: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 146) Method: X-RAY DIFFRACTION / Resolution: 1.84 Å PDB-5q6a: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 147) Method: X-RAY DIFFRACTION / Resolution: 1.71 Å PDB-5q6b: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 148) Method: X-RAY DIFFRACTION / Resolution: 2.62 Å PDB-5q6c: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 149) Method: X-RAY DIFFRACTION / Resolution: 1.53 Å PDB-5q6d: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 150) Method: X-RAY DIFFRACTION / Resolution: 1.48 Å PDB-5q6e: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 151) Method: X-RAY DIFFRACTION / Resolution: 1.47 Å PDB-5q6f: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 152) Method: X-RAY DIFFRACTION / Resolution: 1.55 Å PDB-5q6g: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 153) Method: X-RAY DIFFRACTION / Resolution: 1.48 Å PDB-5q6h: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 154) Method: X-RAY DIFFRACTION / Resolution: 1.42 Å PDB-5q6i: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 155) Method: X-RAY DIFFRACTION / Resolution: 1.68 Å PDB-5q6j: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 156) Method: X-RAY DIFFRACTION / Resolution: 1.7 Å PDB-5q6k: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 157) Method: X-RAY DIFFRACTION / Resolution: 1.67 Å PDB-5q6l: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 158) Method: X-RAY DIFFRACTION / Resolution: 1.82 Å PDB-5q6m: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 159) Method: X-RAY DIFFRACTION / Resolution: 1.47 Å PDB-5q6n: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 160) Method: X-RAY DIFFRACTION / Resolution: 1.52 Å PDB-5q6o: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 161) Method: X-RAY DIFFRACTION / Resolution: 1.4 Å PDB-5q6p: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 162) Method: X-RAY DIFFRACTION / Resolution: 1.54 Å PDB-5q6q: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 163) Method: X-RAY DIFFRACTION / Resolution: 1.36 Å PDB-5q6r: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 164) Method: X-RAY DIFFRACTION / Resolution: 1.42 Å PDB-5q6s: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 165) Method: X-RAY DIFFRACTION / Resolution: 1.56 Å PDB-5q6t: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 166) Method: X-RAY DIFFRACTION / Resolution: 1.59 Å PDB-5q6u: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 167) Method: X-RAY DIFFRACTION / Resolution: 1.33 Å PDB-5q6v: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 168) Method: X-RAY DIFFRACTION / Resolution: 1.29 Å PDB-5q6w: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 169) Method: X-RAY DIFFRACTION / Resolution: 1.5 Å PDB-5q6x: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 170) Method: X-RAY DIFFRACTION / Resolution: 1.43 Å PDB-5q6y: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 171) Method: X-RAY DIFFRACTION / Resolution: 1.67 Å PDB-5q6z: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 172) Method: X-RAY DIFFRACTION / Resolution: 1.62 Å PDB-5q70: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 173) Method: X-RAY DIFFRACTION / Resolution: 1.31 Å PDB-5q71: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 174) Method: X-RAY DIFFRACTION / Resolution: 2 Å PDB-5q72: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 175) Method: X-RAY DIFFRACTION / Resolution: 1.31 Å PDB-5q73: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 176) Method: X-RAY DIFFRACTION / Resolution: 1.36 Å PDB-5q74: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 177) Method: X-RAY DIFFRACTION / Resolution: 1.21 Å PDB-5q75: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 178) Method: X-RAY DIFFRACTION / Resolution: 1.36 Å PDB-5q76: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 179) Method: X-RAY DIFFRACTION / Resolution: 1.28 Å PDB-5q77: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 180) Method: X-RAY DIFFRACTION / Resolution: 2 Å PDB-5q78: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 181) Method: X-RAY DIFFRACTION / Resolution: 1.25 Å PDB-5q79: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 182) Method: X-RAY DIFFRACTION / Resolution: 1.83 Å PDB-5q7a: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 183) Method: X-RAY DIFFRACTION / Resolution: 1.39 Å PDB-5q7b: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 184) Method: X-RAY DIFFRACTION / Resolution: 1.25 Å PDB-5q7c: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 185) Method: X-RAY DIFFRACTION / Resolution: 1.2 Å PDB-5q7d: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 186) Method: X-RAY DIFFRACTION / Resolution: 1.32 Å PDB-5q7e: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 187) Method: X-RAY DIFFRACTION / Resolution: 1.5 Å PDB-5q7f: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 188) Method: X-RAY DIFFRACTION / Resolution: 1.64 Å PDB-5q7g: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 189) Method: X-RAY DIFFRACTION / Resolution: 2 Å PDB-5q7h: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 190) Method: X-RAY DIFFRACTION / Resolution: 2 Å PDB-5q7i: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 191) Method: X-RAY DIFFRACTION / Resolution: 1.26 Å PDB-5q7j: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 192) Method: X-RAY DIFFRACTION / Resolution: 1.54 Å PDB-5q7k: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 193) Method: X-RAY DIFFRACTION / Resolution: 2 Å PDB-5q7l: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 194) Method: X-RAY DIFFRACTION / Resolution: 1.61 Å PDB-5q7m: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 195) Method: X-RAY DIFFRACTION / Resolution: 1.26 Å PDB-5q7n: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 196) Method: X-RAY DIFFRACTION / Resolution: 2 Å PDB-5q7o: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 197) Method: X-RAY DIFFRACTION / Resolution: 1.32 Å PDB-5q7p: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 198) Method: X-RAY DIFFRACTION / Resolution: 2 Å PDB-5q7q: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 199) Method: X-RAY DIFFRACTION / Resolution: 1.76 Å PDB-5q7r: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 200) Method: X-RAY DIFFRACTION / Resolution: 1.62 Å PDB-5q7s: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 201) Method: X-RAY DIFFRACTION / Resolution: 1.31 Å PDB-5q7t: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 202) Method: X-RAY DIFFRACTION / Resolution: 1.67 Å PDB-5q7u: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 203) Method: X-RAY DIFFRACTION / Resolution: 2.11 Å PDB-5q7v: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 204) Method: X-RAY DIFFRACTION / Resolution: 1.62 Å PDB-5q7w: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 205) Method: X-RAY DIFFRACTION / Resolution: 1.27 Å PDB-5q7x: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 206) Method: X-RAY DIFFRACTION / Resolution: 1.69 Å PDB-5q7y: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 207) Method: X-RAY DIFFRACTION / Resolution: 1.39 Å PDB-5q7z: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 208) Method: X-RAY DIFFRACTION / Resolution: 1.65 Å PDB-5q80: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 209) Method: X-RAY DIFFRACTION / Resolution: 1.43 Å PDB-5q81: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 210) Method: X-RAY DIFFRACTION / Resolution: 1.51 Å PDB-5q82: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 211) Method: X-RAY DIFFRACTION / Resolution: 1.2 Å PDB-5q83: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 212) Method: X-RAY DIFFRACTION / Resolution: 1.28 Å PDB-5q84: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 213) Method: X-RAY DIFFRACTION / Resolution: 1.88 Å PDB-5q85: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 214) Method: X-RAY DIFFRACTION / Resolution: 1.8 Å PDB-5q86: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 215) Method: X-RAY DIFFRACTION / Resolution: 1.31 Å PDB-5q87: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 216) Method: X-RAY DIFFRACTION / Resolution: 1.34 Å PDB-5q88: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 217) Method: X-RAY DIFFRACTION / Resolution: 1.78 Å PDB-5q89: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 218) Method: X-RAY DIFFRACTION / Resolution: 1.91 Å PDB-5q8a: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 219) Method: X-RAY DIFFRACTION / Resolution: 1.43 Å PDB-5q8b: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 220) Method: X-RAY DIFFRACTION / Resolution: 1.63 Å PDB-5q8c: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 221) Method: X-RAY DIFFRACTION / Resolution: 2 Å PDB-5q8d: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 222) Method: X-RAY DIFFRACTION / Resolution: 1.23 Å PDB-5q8e: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 223) Method: X-RAY DIFFRACTION / Resolution: 1.63 Å PDB-5q8f: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 224) Method: X-RAY DIFFRACTION / Resolution: 1.36 Å PDB-5q8g: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 225) Method: X-RAY DIFFRACTION / Resolution: 2 Å PDB-5q8h: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 227) Method: X-RAY DIFFRACTION / Resolution: 1.9 Å PDB-5q8i: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 228) Method: X-RAY DIFFRACTION / Resolution: 1.35 Å PDB-5q8j: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 229) Method: X-RAY DIFFRACTION / Resolution: 1.79 Å PDB-5q8k: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 230) Method: X-RAY DIFFRACTION / Resolution: 1.79 Å PDB-5q8l: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 231) Method: X-RAY DIFFRACTION / Resolution: 1.42 Å PDB-5q8m: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 232) Method: X-RAY DIFFRACTION / Resolution: 1.71 Å PDB-5q8n: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 233) Method: X-RAY DIFFRACTION / Resolution: 1.41 Å PDB-5q8o: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 234) Method: X-RAY DIFFRACTION / Resolution: 1.67 Å PDB-5q8p: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 235) Method: X-RAY DIFFRACTION / Resolution: 1.45 Å PDB-5q8q: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 236) Method: X-RAY DIFFRACTION / Resolution: 1.89 Å PDB-5q8r: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 237) Method: X-RAY DIFFRACTION / Resolution: 1.9 Å PDB-5q8s: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 238) Method: X-RAY DIFFRACTION / Resolution: 1.61 Å PDB-5q8t: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 239) Method: X-RAY DIFFRACTION / Resolution: 2 Å PDB-5q8u: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 240) Method: X-RAY DIFFRACTION / Resolution: 1.54 Å PDB-5q8v: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 241) Method: X-RAY DIFFRACTION / Resolution: 1.32 Å PDB-5q8w: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 242) Method: X-RAY DIFFRACTION / Resolution: 1.57 Å PDB-5q8x: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 243) Method: X-RAY DIFFRACTION / Resolution: 1.23 Å PDB-5q8y: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 244) Method: X-RAY DIFFRACTION / Resolution: 1.51 Å PDB-5q8z: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 245) Method: X-RAY DIFFRACTION / Resolution: 1.47 Å PDB-5q90: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 246) Method: X-RAY DIFFRACTION / Resolution: 1.49 Å PDB-5q91: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 247) Method: X-RAY DIFFRACTION / Resolution: 1.46 Å PDB-5q92: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 248) Method: X-RAY DIFFRACTION / Resolution: 2.11 Å PDB-5q93: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 249) Method: X-RAY DIFFRACTION / Resolution: 1.68 Å PDB-5q94: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 250) Method: X-RAY DIFFRACTION / Resolution: 1.9 Å PDB-5q95: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 251) Method: X-RAY DIFFRACTION / Resolution: 1.47 Å PDB-5q96: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 252) Method: X-RAY DIFFRACTION / Resolution: 1.83 Å PDB-5q97: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 253) Method: X-RAY DIFFRACTION / Resolution: 1.97 Å PDB-5q98: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 254) Method: X-RAY DIFFRACTION / Resolution: 1.76 Å PDB-5q99: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 255) Method: X-RAY DIFFRACTION / Resolution: 1.31 Å PDB-5q9a: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 256) Method: X-RAY DIFFRACTION / Resolution: 1.67 Å PDB-5q9b: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 257) Method: X-RAY DIFFRACTION / Resolution: 1.45 Å PDB-5q9c: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 258) Method: X-RAY DIFFRACTION / Resolution: 1.46 Å PDB-5q9d: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 259) Method: X-RAY DIFFRACTION / Resolution: 1.69 Å PDB-5q9e: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 260) Method: X-RAY DIFFRACTION / Resolution: 1.45 Å PDB-5q9f: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 261) Method: X-RAY DIFFRACTION / Resolution: 1.28 Å PDB-5q9g: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 262) Method: X-RAY DIFFRACTION / Resolution: 1.6 Å PDB-5q9h: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 263) Method: X-RAY DIFFRACTION / Resolution: 1.81 Å PDB-5q9i: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 264) Method: X-RAY DIFFRACTION / Resolution: 1.46 Å PDB-5q9j: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 265) Method: X-RAY DIFFRACTION / Resolution: 1.76 Å PDB-5q9k: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 266) Method: X-RAY DIFFRACTION / Resolution: 1.78 Å PDB-5q9l: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 267) Method: X-RAY DIFFRACTION / Resolution: 1.59 Å PDB-5q9m: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 268) Method: X-RAY DIFFRACTION / Resolution: 1.3 Å PDB-5q9n: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 269) Method: X-RAY DIFFRACTION / Resolution: 1.47 Å PDB-5q9o: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 270) Method: X-RAY DIFFRACTION / Resolution: 1.37 Å PDB-5q9p: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 271) Method: X-RAY DIFFRACTION / Resolution: 1.48 Å PDB-5q9q: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 272) Method: X-RAY DIFFRACTION / Resolution: 1.5 Å PDB-5q9r: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 273) Method: X-RAY DIFFRACTION / Resolution: 1.72 Å PDB-5q9s: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 274) Method: X-RAY DIFFRACTION / Resolution: 1.43 Å PDB-5q9t: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 275) Method: X-RAY DIFFRACTION / Resolution: 1.37 Å PDB-5q9u: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 276) Method: X-RAY DIFFRACTION / Resolution: 1.49 Å PDB-5q9v: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 277) Method: X-RAY DIFFRACTION / Resolution: 1.43 Å PDB-5q9w: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 278) Method: X-RAY DIFFRACTION / Resolution: 1.53 Å PDB-5q9x: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 279) Method: X-RAY DIFFRACTION / Resolution: 1.67 Å PDB-5q9y: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 280) Method: X-RAY DIFFRACTION / Resolution: 1.64 Å PDB-5q9z: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 281) Method: X-RAY DIFFRACTION / Resolution: 1.77 Å PDB-5qa0: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 282) Method: X-RAY DIFFRACTION / Resolution: 1.47 Å PDB-5qa1: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 283) Method: X-RAY DIFFRACTION / Resolution: 1.46 Å PDB-5qa2: PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 284) Method: X-RAY DIFFRACTION / Resolution: 1.56 Å PDB-5qha: PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with PCM-0102951 Method: X-RAY DIFFRACTION / Resolution: 1.57 Å PDB-5qht: PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000065a Method: X-RAY DIFFRACTION / Resolution: 1.05 Å PDB-5qhv: PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000299a Method: X-RAY DIFFRACTION / Resolution: 1.05 Å PDB-5qi4: PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000466a Method: X-RAY DIFFRACTION / Resolution: 1.2 Å PDB-5qi6: PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000597a Method: X-RAY DIFFRACTION / Resolution: 1.1 Å PDB-5qi8: PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000605a Method: X-RAY DIFFRACTION / Resolution: 1.09 Å PDB-5qi9: PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000711a Method: X-RAY DIFFRACTION / Resolution: 1.05 Å PDB-5qj5: PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with Z44592329 Method: X-RAY DIFFRACTION / Resolution: 1.72 Å PDB-5qoh: PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with XST00000847b Method: X-RAY DIFFRACTION / Resolution: 1.93 Å PDB-5qoi: PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with FMOPL000213a Method: X-RAY DIFFRACTION / Resolution: 1.99 Å PDB-5qoj: PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with FMOCR000171b Method: X-RAY DIFFRACTION / Resolution: 2.05 Å PDB-5qok: PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with FMOPL000294a Method: X-RAY DIFFRACTION / Resolution: 2.28 Å PDB-5qol: PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with FMOPL000435a Method: X-RAY DIFFRACTION / Resolution: 1.85 Å PDB-5qom: PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with FMOPL000576a Method: X-RAY DIFFRACTION / Resolution: 1.87 Å PDB-5qon: PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with FMOPL000446a Method: X-RAY DIFFRACTION / Resolution: 1.8 Å PDB-5qoo: PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with FMOPL000144a Method: X-RAY DIFFRACTION / Resolution: 1.56 Å PDB-5qop: PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with NUOOA000023a Method: X-RAY DIFFRACTION / Resolution: 1.86 Å PDB-5qoq: PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z2895259680 Method: X-RAY DIFFRACTION / Resolution: 1.49 Å PDB-5qor: PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z1203490773 Method: X-RAY DIFFRACTION / Resolution: 1.95 Å PDB-5qos: PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z1187701032 Method: X-RAY DIFFRACTION / Resolution: 1.7 Å PDB-5qot: PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z1592710382 Method: X-RAY DIFFRACTION / Resolution: 1.68 Å PDB-5qou: PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z296300542 Method: X-RAY DIFFRACTION / Resolution: 2.19 Å PDB-5qov: PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z1699011516 Method: X-RAY DIFFRACTION / Resolution: 1.65 Å PDB-5qow: PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z2895259675 Method: X-RAY DIFFRACTION / Resolution: 1.82 Å PDB-5qox: PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z2212124043 Method: X-RAY DIFFRACTION / Resolution: 1.95 Å PDB-5qoy: PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with YW-FY-378 Method: X-RAY DIFFRACTION / Resolution: 1.69 Å PDB-5qoz: PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with PB1787571279 Method: X-RAY DIFFRACTION / Resolution: 1.7 Å PDB-5qp0: PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z454376544 Method: X-RAY DIFFRACTION / Resolution: 2 Å PDB-5qp1: PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z1190363272 Method: X-RAY DIFFRACTION / Resolution: 1.79 Å PDB-5qp2: PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z1170065264 Method: X-RAY DIFFRACTION / Resolution: 1.83 Å PDB-5qp3: PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z1494850193 Method: X-RAY DIFFRACTION / Resolution: 1.75 Å PDB-5qp4: PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z450133538 Method: X-RAY DIFFRACTION / Resolution: 1.71 Å PDB-5qp5: PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z2895259681 Method: X-RAY DIFFRACTION / Resolution: 1.9 Å PDB-5qp6: PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z1662802141 Method: X-RAY DIFFRACTION / Resolution: 1.65 Å PDB-5qp7: PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with PB1230873739 Method: X-RAY DIFFRACTION / Resolution: 1.88 Å PDB-5qp8: PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with PB1787571279 Method: X-RAY DIFFRACTION / Resolution: 1.64 Å PDB-5qp9: PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z100435060 Method: X-RAY DIFFRACTION / Resolution: 1.72 Å PDB-5qpa: PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with FMOPL000449a Method: X-RAY DIFFRACTION / Resolution: 1.61 Å PDB-5qpb: PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with FMOPL000701a Method: X-RAY DIFFRACTION / Resolution: 1.68 Å PDB-5qqd: PanDDA analysis group deposition -- Crystal Structure of Kalirin/Rac1 in complex with Z56880342 Method: X-RAY DIFFRACTION / Resolution: 1.91 Å PDB-5qqe: PanDDA analysis group deposition -- Crystal Structure of Kalirin/Rac1 in complex with MolPort-009-531-494 Method: X-RAY DIFFRACTION / Resolution: 1.95 Å PDB-5qqf: PanDDA analysis group deposition -- Crystal Structure of Kalirin/Rac1 in complex with MolPort-004-412-710 Method: X-RAY DIFFRACTION / Resolution: 2.26 Å PDB-5qqg: PanDDA analysis group deposition -- Crystal Structure of Kalirin/Rac1 in complex with MolPort-009-541-216 Method: X-RAY DIFFRACTION / Resolution: 2.23 Å PDB-5qqh: PanDDA analysis group deposition -- Crystal Structure of Kalirin/Rac1 in complex with MolPort-020-096-465 Method: X-RAY DIFFRACTION / Resolution: 2.09 Å PDB-5qqi: PanDDA analysis group deposition -- Crystal Structure of Kalirin/Rac1 in complex with MolPort-009-178-994 Method: X-RAY DIFFRACTION / Resolution: 2.08 Å PDB-5qqj: PanDDA analysis group deposition -- Crystal Structure of Kalirin/Rac1 in complex with MolPort-009-587-558 Method: X-RAY DIFFRACTION / Resolution: 1.9 Å PDB-5qqk: PanDDA analysis group deposition -- Crystal Structure of Kalirin/Rac1 in complex with MolPort-009-359-835 Method: X-RAY DIFFRACTION / Resolution: 2.24 Å PDB-5qql: PanDDA analysis group deposition -- Crystal Structure of Kalirin/Rac1 in complex with MolPort-009-565-301 Method: X-RAY DIFFRACTION / Resolution: 2.25 Å PDB-5qqm: PanDDA analysis group deposition -- Crystal Structure of Kalirin/Rac1 in complex with MolPort-009-565-325 Method: X-RAY DIFFRACTION / Resolution: 2.02 Å PDB-5qqn: PanDDA analysis group deposition -- Crystal Structure of Kalirin/Rac1 in complex with MolPort-010-382-606 Method: X-RAY DIFFRACTION / Resolution: 2.26 Å PDB-5qqq: PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z2856434857 Method: X-RAY DIFFRACTION / Resolution: 1.93 Å PDB-5qqr: PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z1171217421 Method: X-RAY DIFFRACTION / Resolution: 1.46 Å PDB-5qqs: PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z275151340 Method: X-RAY DIFFRACTION / Resolution: 1.85 Å PDB-5qqt: PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z2856434834 Method: X-RAY DIFFRACTION / Resolution: 1.67 Å PDB-5qqu: PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z1348371854 Method: X-RAY DIFFRACTION / Resolution: 1.55 Å PDB-5qqv: PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z1545312521 Method: X-RAY DIFFRACTION / Resolution: 1.52 Å PDB-5qqw: PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z136583524 Method: X-RAY DIFFRACTION / Resolution: 1.56 Å PDB-5qqx: PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z373768900 Method: X-RAY DIFFRACTION / Resolution: 1.5 Å PDB-5qqy: PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z2856434899 Method: X-RAY DIFFRACTION / Resolution: 1.49 Å PDB-5qqz: PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z1675346324 Method: X-RAY DIFFRACTION / Resolution: 1.55 Å PDB-5qr0: PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z730649594 Method: X-RAY DIFFRACTION / Resolution: 1.65 Å PDB-5qr1: PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z396380540 Method: X-RAY DIFFRACTION / Resolution: 1.44 Å PDB-5qr2: PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z1348371854 Method: X-RAY DIFFRACTION / Resolution: 1.66 Å PDB-5qr3: PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z915492990 Method: X-RAY DIFFRACTION / Resolution: 1.71 Å PDB-5qr4: PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z2856434826 Method: X-RAY DIFFRACTION / Resolution: 1.57 Å PDB-5qr5: PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z2241115980 Method: X-RAY DIFFRACTION / Resolution: 1.49 Å PDB-5qr6: PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z44567722 Method: X-RAY DIFFRACTION / Resolution: 1.52 Å PDB-5qr7: PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z57299529 Method: X-RAY DIFFRACTION / Resolution: 1.74 Å PDB-5qr8: PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z57258487 Method: X-RAY DIFFRACTION / Resolution: 1.85 Å PDB-5qr9: PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z31478129 Method: X-RAY DIFFRACTION / Resolution: 1.62 Å PDB-5qra: PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z1101755952 Method: X-RAY DIFFRACTION / Resolution: 1.72 Å PDB-5qrb: PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z2856434868 Method: X-RAY DIFFRACTION / Resolution: 1.72 Å PDB-5qrc: PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z31721798 Method: X-RAY DIFFRACTION / Resolution: 1.82 Å PDB-5qrd: PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z1328968520 Method: X-RAY DIFFRACTION / Resolution: 1.76 Å PDB-5qre: PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z117233350 Method: X-RAY DIFFRACTION / Resolution: 1.67 Å PDB-5qrf: PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z373768900 Method: X-RAY DIFFRACTION / Resolution: 2.03 Å PDB-5qrg: PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z275151340 Method: X-RAY DIFFRACTION / Resolution: 1.95 Å PDB-5qrh: PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z32327641 Method: X-RAY DIFFRACTION / Resolution: 1.81 Å PDB-5qri: PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z2856434826 Method: X-RAY DIFFRACTION / Resolution: 1.83 Å PDB-5qrj: PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z416341642 Method: X-RAY DIFFRACTION / Resolution: 1.81 Å PDB-5qrk: PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z275179758 Method: X-RAY DIFFRACTION / Resolution: 1.63 Å PDB-5qrl: PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z437516460 Method: X-RAY DIFFRACTION / Resolution: 1.76 Å PDB-5qrm: PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z1899842917 Method: X-RAY DIFFRACTION / Resolution: 1.55 Å PDB-5qrn: PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z54226006 Method: X-RAY DIFFRACTION / Resolution: 1.62 Å PDB-5qro: PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z1506050651 Method: X-RAY DIFFRACTION / Resolution: 1.61 Å PDB-5qrp: PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z2442270563 Method: X-RAY DIFFRACTION / Resolution: 1.67 Å PDB-5qrq: PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z645232558 Method: X-RAY DIFFRACTION / Resolution: 2.1 Å PDB-5qrr: PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z31720228 Method: X-RAY DIFFRACTION / Resolution: 1.69 Å PDB-5qrs: PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z1891773393 Method: X-RAY DIFFRACTION / Resolution: 2.06 Å PDB-5qrt: PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z31735562 Method: X-RAY DIFFRACTION / Resolution: 1.77 Å PDB-5qru: PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z235341991 Method: X-RAY DIFFRACTION / Resolution: 1.76 Å PDB-5qrv: PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z198194396 Method: X-RAY DIFFRACTION / Resolution: 1.67 Å PDB-5qrw: PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z1509882419 Method: X-RAY DIFFRACTION / Resolution: 1.74 Å PDB-5qrx: PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z364328788 Method: X-RAY DIFFRACTION / Resolution: 1.87 Å PDB-5qry: PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z2856434890 Method: X-RAY DIFFRACTION / Resolution: 1.58 Å PDB-5qrz: PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z1998104358 Method: X-RAY DIFFRACTION / Resolution: 1.96 Å PDB-5qs0: PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z274555794 Method: X-RAY DIFFRACTION / Resolution: 1.6 Å PDB-5qs1: PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z1954800564 Method: X-RAY DIFFRACTION / Resolution: 1.66 Å PDB-5qs2: PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z291279160 Method: X-RAY DIFFRACTION / Resolution: 1.68 Å PDB-5qs3: PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z198195770 Method: X-RAY DIFFRACTION / Resolution: 1.71 Å PDB-5qs4: PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z30820160 Method: X-RAY DIFFRACTION / Resolution: 1.65 Å PDB-5qs5: PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z32400357 Method: X-RAY DIFFRACTION / Resolution: 1.81 Å PDB-5qs6: PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z44592329 Method: X-RAY DIFFRACTION / Resolution: 1.67 Å PDB-5qs7: PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z32327641 Method: X-RAY DIFFRACTION / Resolution: 1.66 Å PDB-5qs8: PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z1432018343 Method: X-RAY DIFFRACTION / Resolution: 1.47 Å PDB-5qs9: PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z48847594 Method: X-RAY DIFFRACTION / Resolution: 1.43 Å PDB-5qsa: PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z2856434778 Method: X-RAY DIFFRACTION / Resolution: 1.55 Å PDB-5qsb: PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z2856434874 Method: X-RAY DIFFRACTION / Resolution: 1.82 Å PDB-5qsc: PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z300245038 Method: X-RAY DIFFRACTION / Resolution: 1.62 Å PDB-5qsd: PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z54571979 Method: X-RAY DIFFRACTION / Resolution: 1.87 Å PDB-5qse: PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z2017168803 Method: X-RAY DIFFRACTION / Resolution: 2.01 Å PDB-5qsf: PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z2856434814 Method: X-RAY DIFFRACTION / Resolution: 1.96 Å PDB-5qsg: PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z2856434903 Method: X-RAY DIFFRACTION / Resolution: 1.87 Å PDB-5qsh: PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z2856434868 Method: X-RAY DIFFRACTION / Resolution: 1.9 Å PDB-5qsi: PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z933326822 Method: X-RAY DIFFRACTION / Resolution: 1.64 Å PDB-5qsj: PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z198194394 Method: X-RAY DIFFRACTION / Resolution: 1.49 Å PDB-5qsk: PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z2856434906 Method: X-RAY DIFFRACTION / Resolution: 1.55 Å PDB-5qsl: PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z1273312153 Method: X-RAY DIFFRACTION / Resolution: 2.2 Å PDB-5qsm: PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z57261895 Method: X-RAY DIFFRACTION / Resolution: 2.74 Å PDB-5qsn: PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z1272480091 Method: X-RAY DIFFRACTION / Resolution: 2.66 Å PDB-5qso: PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z466628048 Method: X-RAY DIFFRACTION / Resolution: 2.7 Å PDB-5qsp: PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z2856434929 Method: X-RAY DIFFRACTION / Resolution: 2.89 Å PDB-5qsq: PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z396380540 Method: X-RAY DIFFRACTION / Resolution: 2.48 Å PDB-5qsr: PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z136583524 Method: X-RAY DIFFRACTION / Resolution: 3.28 Å PDB-5qss: PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z33452282 Method: X-RAY DIFFRACTION / Resolution: 3.08 Å PDB-5qst: PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z2447286438 Method: X-RAY DIFFRACTION / Resolution: 2.58 Å PDB-5qsu: PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z2856434926 Method: X-RAY DIFFRACTION / Resolution: 2.73 Å PDB-5qsv: PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z2856434783 Method: X-RAY DIFFRACTION / Resolution: 2.76 Å PDB-5qsw: PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z2856434884 Method: X-RAY DIFFRACTION / Resolution: 3.03 Å PDB-5qsx: PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z2856434812 Method: X-RAY DIFFRACTION / Resolution: 2.34 Å PDB-5qsy: PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z755044716 Method: X-RAY DIFFRACTION / Resolution: 2.4 Å PDB-5qsz: PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z1267773786 Method: X-RAY DIFFRACTION / Resolution: 3.08 Å PDB-5qt0: PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z321318226 Method: X-RAY DIFFRACTION / Resolution: 2.1 Å PDB-5qt1: PanDDA analysis group deposition -- Partial occupancy interpretation of PanDDA event map: SETDB1 in complex with FMOMB000017a Method: X-RAY DIFFRACTION / Resolution: 1.58 Å PDB-5qt2: PanDDA analysis group deposition -- Partial occupancy interpretation of PanDDA event map: SETDB1 in complex with FMOPL000074a Method: X-RAY DIFFRACTION / Resolution: 1.59 Å PDB-5qtl: PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with GB-0804 Method: X-RAY DIFFRACTION / Resolution: 1.73 Å PDB-5qtm: PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with FS-2639 Method: X-RAY DIFFRACTION / Resolution: 1.79 Å PDB-5qtn: PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with SS-4432 Method: X-RAY DIFFRACTION / Resolution: 1.83 Å PDB-5qto: PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with 1R-0641 Method: X-RAY DIFFRACTION / Resolution: 1.67 Å PDB-5qtp: PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with AE-0227 Method: X-RAY DIFFRACTION / Resolution: 1.73 Å PDB-5qtq: PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with FS-1169 Method: X-RAY DIFFRACTION / Resolution: 1.82 Å PDB-5qtr: PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with FS-3764 Method: X-RAY DIFFRACTION / Resolution: 1.55 Å PDB-5qts: PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with 8J-537S Method: X-RAY DIFFRACTION / Resolution: 1.85 Å PDB-5r4g: PanDDA analysis group deposition -- CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN NUCLEOSOME-REMODELING FACTOR SUBUNIT BPTF in complex with FMOPL000621a Method: X-RAY DIFFRACTION / Resolution: 1.25 Å PDB-5r4h: PanDDA analysis group deposition -- CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN NUCLEOSOME-REMODELING FACTOR SUBUNIT BPTF in complex with FMOPL000287a Method: X-RAY DIFFRACTION / Resolution: 1.18 Å PDB-5r4i: PanDDA analysis group deposition -- CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN NUCLEOSOME-REMODELING FACTOR SUBUNIT BPTF in complex with FMOPL000443a Method: X-RAY DIFFRACTION / Resolution: 1.28 Å PDB-5r4j: PanDDA analysis group deposition -- CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN NUCLEOSOME-REMODELING FACTOR SUBUNIT BPTF in complex with FMOPL000280a Method: X-RAY DIFFRACTION / Resolution: 1.39 Å PDB-5r4k: PanDDA analysis group deposition -- CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN NUCLEOSOME-REMODELING FACTOR SUBUNIT BPTF in complex with FMOPL000292a Method: X-RAY DIFFRACTION / Resolution: 1.17 Å PDB-5r4l: PanDDA analysis group deposition -- CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN NUCLEOSOME-REMODELING FACTOR SUBUNIT BPTF in complex with FMOPL000349a Method: X-RAY DIFFRACTION / Resolution: 1.13 Å PDB-5r4m: PanDDA analysis group deposition -- CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN NUCLEOSOME-REMODELING FACTOR SUBUNIT BPTF in complex with FMOPL000513a Method: X-RAY DIFFRACTION / Resolution: 1.11 Å PDB-5r4n: PanDDA analysis group deposition -- CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN NUCLEOSOME-REMODELING FACTOR SUBUNIT BPTF in complex with FMOPL000061a Method: X-RAY DIFFRACTION / Resolution: 1.28 Å PDB-5r4p: PanDDA analysis group deposition -- Crystal Structure of HUMAN CLEAVAGE FACTOR IM in complex with NM450-1 Method: X-RAY DIFFRACTION / Resolution: 1.78 Å PDB-5r4q: PanDDA analysis group deposition -- Crystal Structure of HUMAN CLEAVAGE FACTOR IM in complex with NM466-1 Method: X-RAY DIFFRACTION / Resolution: 1.49 Å PDB-5r4r: PanDDA analysis group deposition -- Crystal Structure of HUMAN CLEAVAGE FACTOR IM in complex with EN08775-42 Method: X-RAY DIFFRACTION / Resolution: 1.5 Å PDB-5r4s: PanDDA analysis group deposition -- Crystal Structure of HUMAN CLEAVAGE FACTOR IM in complex with EN08775-45 Method: X-RAY DIFFRACTION / Resolution: 1.61 Å PDB-5r4t: PanDDA analysis group deposition -- Crystal Structure of HUMAN CLEAVAGE FACTOR IM in complex with SK-430 Method: X-RAY DIFFRACTION / Resolution: 1.68 Å PDB-5r4u: PanDDA analysis group deposition -- Crystal Structure of HUMAN CLEAVAGE FACTOR IM in complex with EN08775-43 Method: X-RAY DIFFRACTION / Resolution: 1.92 Å PDB-5r50: PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13371a Method: X-RAY DIFFRACTION / Resolution: 1.87 Å PDB-5r51: PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N14003a Method: X-RAY DIFFRACTION / Resolution: 1.65 Å PDB-5r52: PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N14004a Method: X-RAY DIFFRACTION / Resolution: 1.48 Å PDB-5r53: PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13854a Method: X-RAY DIFFRACTION / Resolution: 1.4 Å PDB-5r54: PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13582a Method: X-RAY DIFFRACTION / Resolution: 1.79 Å PDB-5r55: PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13369a Method: X-RAY DIFFRACTION / Resolution: 1.48 Å PDB-5r56: PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13688a Method: X-RAY DIFFRACTION / Resolution: 1.51 Å PDB-5r57: PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N08253b Method: X-RAY DIFFRACTION / Resolution: 1.44 Å PDB-5r58: PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13542a Method: X-RAY DIFFRACTION / Resolution: 1.98 Å PDB-5r59: PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13441a Method: X-RAY DIFFRACTION / Resolution: 2.11 Å PDB-5r5a: PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13663a Method: X-RAY DIFFRACTION / Resolution: 1.44 Å PDB-5r5b: PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13725a Method: X-RAY DIFFRACTION / Resolution: 1.53 Å PDB-5r5c: PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13956a Method: X-RAY DIFFRACTION / Resolution: 1.68 Å PDB-5r5d: PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13564a Method: X-RAY DIFFRACTION / Resolution: 1.65 Å PDB-5r5e: PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13848a Method: X-RAY DIFFRACTION / Resolution: 1.58 Å PDB-5r5f: PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13793a Method: X-RAY DIFFRACTION / Resolution: 1.63 Å PDB-5r5g: PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13707a Method: X-RAY DIFFRACTION / Resolution: 1.77 Å PDB-5r5h: PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13706a Method: X-RAY DIFFRACTION / Resolution: 1.79 Å PDB-5r5i: PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N06325b Method: X-RAY DIFFRACTION / Resolution: 1.7 Å PDB-5r5j: PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13964a Method: X-RAY DIFFRACTION / Resolution: 1.98 Å PDB-5r5k: PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13960a Method: X-RAY DIFFRACTION / Resolution: 1.6 Å PDB-5r5l: PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13589a Method: X-RAY DIFFRACTION / Resolution: 1.63 Å PDB-5r5m: PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N14123a Method: X-RAY DIFFRACTION / Resolution: 1.6 Å PDB-5r5n: PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13595a Method: X-RAY DIFFRACTION / Resolution: 1.87 Å PDB-5r5o: PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N14027a Method: X-RAY DIFFRACTION / Resolution: 1.79 Å PDB-5r5p: PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13910a Method: X-RAY DIFFRACTION / Resolution: 1.53 Å PDB-5r5q: PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13920a Method: X-RAY DIFFRACTION / Resolution: 1.71 Å PDB-5r5r: PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N14078a Method: X-RAY DIFFRACTION / Resolution: 1.65 Å PDB-5r5s: PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13775a Method: X-RAY DIFFRACTION / Resolution: 1.5 Å PDB-5r5t: PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z1251207602 Method: X-RAY DIFFRACTION / Resolution: 1.55 Å PDB-5r5u: PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z1545312521 Method: X-RAY DIFFRACTION / Resolution: 1.52 Å PDB-5r5v: PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z2856434824 Method: X-RAY DIFFRACTION / Resolution: 1.7 Å PDB-5r5w: PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z2856434942 Method: X-RAY DIFFRACTION / Resolution: 1.6 Å PDB-5r5x: PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z1259335913 Method: X-RAY DIFFRACTION / Resolution: 1.56 Å PDB-5r5y: PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z509756472 Method: X-RAY DIFFRACTION / Resolution: 1.57 Å PDB-5r5z: PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z2856434821 Method: X-RAY DIFFRACTION / Resolution: 1.67 Å PDB-5r60: PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z19735067 Method: X-RAY DIFFRACTION / Resolution: 1.79 Å PDB-5r61: PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z1578665941 Method: X-RAY DIFFRACTION / Resolution: 1.38 Å PDB-5r62: PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z2856434840 Method: X-RAY DIFFRACTION / Resolution: 1.4 Å PDB-5r63: PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z319545618 Method: X-RAY DIFFRACTION / Resolution: 1.59 Å PDB-5r64: PanDDA analysis group deposition -- Crystal Structure of HUMAN CLEAVAGE FACTOR IM in complex with FMOPL000464a Method: X-RAY DIFFRACTION / Resolution: 1.84 Å PDB-5r65: PanDDA analysis group deposition -- Crystal Structure of HUMAN CLEAVAGE FACTOR IM in complex with FMOPL000387a Method: X-RAY DIFFRACTION / Resolution: 2.28 Å PDB-5r66: PanDDA analysis group deposition -- Crystal Structure of HUMAN CLEAVAGE FACTOR IM in complex with FMOPL000198a Method: X-RAY DIFFRACTION / Resolution: 2.02 Å PDB-5r67: PanDDA analysis group deposition -- Crystal Structure of HUMAN CLEAVAGE FACTOR IM in complex with FMOPL000589a Method: X-RAY DIFFRACTION / Resolution: 1.52 Å PDB-5rhg: PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z235341991 Method: X-RAY DIFFRACTION / Resolution: 1.41 Å PDB-5rhh: PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z1515654336 Method: X-RAY DIFFRACTION / Resolution: 1.59 Å PDB-5rhi: PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z198194396 Method: X-RAY DIFFRACTION / Resolution: 1.45 Å PDB-5rhj: PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z126932614 Method: X-RAY DIFFRACTION / Resolution: 1.5 Å PDB-5rhk: PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z87615031 Method: X-RAY DIFFRACTION / Resolution: 1.52 Å PDB-5rhl: PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z425387594 Method: X-RAY DIFFRACTION / Resolution: 1.43 Å PDB-5rhm: PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z1454310449 Method: X-RAY DIFFRACTION / Resolution: 1.68 Å PDB-5rho: PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z1444783243 Method: X-RAY DIFFRACTION / Resolution: 1.49 Å PDB-5rhp: PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z2856434938 Method: X-RAY DIFFRACTION / Resolution: 1.61 Å PDB-5rhq: PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z235449082 Method: X-RAY DIFFRACTION / Resolution: 1.49 Å PDB-5rhr: PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z1348559502 Method: X-RAY DIFFRACTION / Resolution: 1.46 Å PDB-5rhs: PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z274555794 Method: X-RAY DIFFRACTION / Resolution: 1.53 Å PDB-5rht: PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z291279160 Method: X-RAY DIFFRACTION / Resolution: 1.63 Å PDB-5rhu: PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z1703168683 Method: X-RAY DIFFRACTION / Resolution: 1.61 Å PDB-5rhv: PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z62645406 Method: X-RAY DIFFRACTION / Resolution: 1.71 Å PDB-5rhw: PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z31222641 Method: X-RAY DIFFRACTION / Resolution: 1.62 Å PDB-5rhx: PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z1324080698 Method: X-RAY DIFFRACTION / Resolution: 1.73 Å PDB-5rvw: PanDDA analysis group deposition -- Crystal Structure of DHTKD1 in complex with Z1587220559 Method: X-RAY DIFFRACTION / Resolution: 1.614 Å PDB-5rvx: PanDDA analysis group deposition -- Crystal Structure of DHTKD1 in complex with Z804566442 Method: X-RAY DIFFRACTION / Resolution: 1.661 Å PDB-5rvy: PanDDA analysis group deposition -- Crystal Structure of DHTKD1 in complex with Z437516460 Method: X-RAY DIFFRACTION / Resolution: 1.609 Å PDB-5rvz: PanDDA analysis group deposition -- Crystal Structure of DHTKD1 in complex with Z1929757385 Method: X-RAY DIFFRACTION / Resolution: 1.98 Å PDB-5rw0: PanDDA analysis group deposition -- Crystal Structure of DHTKD1 in complex with Z2444997446 Method: X-RAY DIFFRACTION / Resolution: 1.673 Å PDB-5sdc: PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z2856434912 Method: X-RAY DIFFRACTION / Resolution: 1.928 Å PDB-5sdd: PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z2856434879 Method: X-RAY DIFFRACTION / Resolution: 1.839 Å PDB-5sde: PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z1619978933 Method: X-RAY DIFFRACTION / Resolution: 1.854 Å PDB-5sdf: PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z2856434834 Method: X-RAY DIFFRACTION / Resolution: 1.877 Å PDB-5sdg: PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z136583524 Method: X-RAY DIFFRACTION / Resolution: 1.95 Å PDB-5sdh: PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z2856434854 Method: X-RAY DIFFRACTION / Resolution: 2.313 Å PDB-5sdi: PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z44592329 Method: X-RAY DIFFRACTION / Resolution: 1.898 Å PDB-5sdj: PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z32327641 Method: X-RAY DIFFRACTION / Resolution: 2.041 Å PDB-5sdk: PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z416341642 Method: X-RAY DIFFRACTION / Resolution: 1.977 Å PDB-5sdl: PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z321318226 Method: X-RAY DIFFRACTION / Resolution: 2.44 Å PDB-5sdm: PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z1328078283 Method: X-RAY DIFFRACTION / Resolution: 2.039 Å PDB-5sdn: PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z437584380 Method: X-RAY DIFFRACTION / Resolution: 2.023 Å PDB-5sdo: PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z19735067 Method: X-RAY DIFFRACTION / Resolution: 2.051 Å PDB-5sdp: PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z2277255954 Method: X-RAY DIFFRACTION / Resolution: 2.195 Å PDB-5sdq: PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z2856434887 Method: X-RAY DIFFRACTION / Resolution: 1.92 Å PDB-5sdr: PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z1273312153 Method: X-RAY DIFFRACTION / Resolution: 2.077 Å PDB-5skw: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1272494722 Method: X-RAY DIFFRACTION / Resolution: 2.093 Å PDB-5skx: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z126932614 Method: X-RAY DIFFRACTION / Resolution: 2.342 Å PDB-5sky: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z466628048 Method: X-RAY DIFFRACTION / Resolution: 2.25 Å PDB-5skz: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z57258487 Method: X-RAY DIFFRACTION / Resolution: 1.96 Å PDB-5sl0: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z57260516 Method: X-RAY DIFFRACTION / Resolution: 2.001 Å PDB-5sl1: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1273312153 Method: X-RAY DIFFRACTION / Resolution: 2.383 Å PDB-5sl2: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z100643660 Method: X-RAY DIFFRACTION / Resolution: 1.739 Å PDB-5sl3: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z223688272 Method: X-RAY DIFFRACTION / Resolution: 1.99 Å PDB-5sl4: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z383202616 Method: X-RAY DIFFRACTION / Resolution: 1.936 Å PDB-5sl5: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z32014663 Method: X-RAY DIFFRACTION / Resolution: 2.36 Å PDB-5sl6: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z256709556 Method: X-RAY DIFFRACTION / Resolution: 2.289 Å PDB-5sl7: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1186029914 Method: X-RAY DIFFRACTION / Resolution: 1.841 Å PDB-5sl8: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z2856434762 Method: X-RAY DIFFRACTION / Resolution: 2.07 Å PDB-5sl9: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z54571979 Method: X-RAY DIFFRACTION / Resolution: 1.749 Å PDB-5sla: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1003207278 Method: X-RAY DIFFRACTION / Resolution: 1.7 Å PDB-5slb: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z744930860 Method: X-RAY DIFFRACTION / Resolution: 1.8 Å PDB-5slc: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1849009686 Method: X-RAY DIFFRACTION / Resolution: 1.668 Å PDB-5sld: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1246465616 Method: X-RAY DIFFRACTION / Resolution: 1.581 Å PDB-5sle: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z56880342 Method: X-RAY DIFFRACTION / Resolution: 2.009 Å PDB-5slf: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z198195770 Method: X-RAY DIFFRACTION / Resolution: 2.01 Å PDB-5slg: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z32400357 Method: X-RAY DIFFRACTION / Resolution: 1.97 Å PDB-5slh: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z65532537 Method: X-RAY DIFFRACTION / Resolution: 1.819 Å PDB-5sli: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1003146540 Method: X-RAY DIFFRACTION / Resolution: 2.3 Å PDB-5slj: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1430613393 Method: X-RAY DIFFRACTION / Resolution: 2.31 Å PDB-5slk: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1354370680 Method: X-RAY DIFFRACTION / Resolution: 2.21 Å PDB-5sll: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z54615640 Method: X-RAY DIFFRACTION / Resolution: 1.807 Å PDB-5slm: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z28290384 Method: X-RAY DIFFRACTION / Resolution: 2.05 Å PDB-5sln: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z57299529 Method: X-RAY DIFFRACTION / Resolution: 2.208 Å PDB-5slo: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z56983806 Method: X-RAY DIFFRACTION / Resolution: 1.829 Å PDB-5slp: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z373768898 Method: X-RAY DIFFRACTION / Resolution: 1.819 Å PDB-5slq: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z2856434829 Method: X-RAY DIFFRACTION / Resolution: 2.112 Å PDB-5slr: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z2073741691 Method: X-RAY DIFFRACTION / Resolution: 1.86 Å PDB-5sls: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1373445602 Method: X-RAY DIFFRACTION / Resolution: 2.29 Å PDB-5slt: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1816233707 Method: X-RAY DIFFRACTION / Resolution: 1.901 Å PDB-5slu: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1796014543 Method: X-RAY DIFFRACTION / Resolution: 2.09 Å PDB-5slv: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z2856434942 Method: X-RAY DIFFRACTION / Resolution: 2.049 Å PDB-5slw: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1310876699 Method: X-RAY DIFFRACTION / Resolution: 2.05 Å PDB-5slx: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z752989138 Method: X-RAY DIFFRACTION / Resolution: 1.76 Å PDB-5sly: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1526504764 Method: X-RAY DIFFRACTION / Resolution: 2.018 Å PDB-5slz: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z2072621991 Method: X-RAY DIFFRACTION / Resolution: 2.54 Å PDB-5sm0: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z32665176 Method: X-RAY DIFFRACTION / Resolution: 2.086 Å PDB-5sm1: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z68277692 Method: X-RAY DIFFRACTION / Resolution: 1.941 Å PDB-5sm2: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z3006151474 Method: X-RAY DIFFRACTION / Resolution: 1.781 Å PDB-5sm3: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z943693514 Method: X-RAY DIFFRACTION / Resolution: 2.198 Å PDB-5sm4: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z2856434944 Method: X-RAY DIFFRACTION / Resolution: 2.16 Å PDB-5sm5: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z2856434807 Method: X-RAY DIFFRACTION / Resolution: 1.95 Å PDB-5sm6: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1899842917 Method: X-RAY DIFFRACTION / Resolution: 2.29 Å PDB-5sm7: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1247413608 Method: X-RAY DIFFRACTION / Resolution: 1.95 Å PDB-5sm8: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z2027158783 Method: X-RAY DIFFRACTION / Resolution: 1.95 Å PDB-5sm9: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z2234920345 Method: X-RAY DIFFRACTION / Resolution: 2.01 Å PDB-5sma: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z2856434890 Method: X-RAY DIFFRACTION / Resolution: 2.011 Å PDB-5smb: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z419995480 Method: X-RAY DIFFRACTION / Resolution: 2.181 Å PDB-5smc: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z2033637875 Method: X-RAY DIFFRACTION / Resolution: 2.19 Å PDB-5smd: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z274575916 Method: X-RAY DIFFRACTION / Resolution: 1.826 Å PDB-5sme: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z437584380 Method: X-RAY DIFFRACTION / Resolution: 1.91 Å PDB-5smf: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z56791867 Method: X-RAY DIFFRACTION / Resolution: 2.011 Å PDB-5smg: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z2092370954 Method: X-RAY DIFFRACTION / Resolution: 1.87 Å PDB-5smh: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z2856434938 Method: X-RAY DIFFRACTION / Resolution: 2.64 Å PDB-5smi: PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z71580604 Method: X-RAY DIFFRACTION / Resolution: 2.08 Å PDB-7fus: PanDDA analysis group deposition -- PHIP in complex with Z44602363 Method: X-RAY DIFFRACTION / Resolution: 1.15 Å PDB-7fut: PanDDA analysis group deposition -- PHIP in complex with Z44602357 Method: X-RAY DIFFRACTION / Resolution: 1.18 Å PDB-7fuu: PanDDA analysis group deposition -- PHIP in complex with Z445977856 Method: X-RAY DIFFRACTION / Resolution: 1.16 Å PDB-7fuv: PanDDA analysis group deposition -- PHIP in complex with Z183376720 Method: X-RAY DIFFRACTION / Resolution: 1.19 Å PDB-7fuw: PanDDA analysis group deposition -- PHIP in complex with Z961579360 Method: X-RAY DIFFRACTION / Resolution: 1.19 Å PDB-7fux: PanDDA analysis group deposition -- PHIP in complex with Z183480798 Method: X-RAY DIFFRACTION / Resolution: 1.22 Å PDB-7fuy: PanDDA analysis group deposition -- PHIP in complex with Z1284554279 Method: X-RAY DIFFRACTION / Resolution: 1.15 Å PDB-7fuz: PanDDA analysis group deposition -- PHIP in complex with Z4307421429 Method: X-RAY DIFFRACTION / Resolution: 1.43 Å PDB-7fv0: PanDDA analysis group deposition -- PHIP in complex with Z44602337 Method: X-RAY DIFFRACTION / Resolution: 1.21 Å PDB-7fv1: PanDDA analysis group deposition -- PHIP in complex with Z4912742920 Method: X-RAY DIFFRACTION / Resolution: 1.19 Å PDB-7fv2: PanDDA analysis group deposition -- PHIP in complex with Z445899798 Method: X-RAY DIFFRACTION / Resolution: 1.15 Å PDB-7fv3: PanDDA analysis group deposition -- PHIP in complex with Z4912742924 Method: X-RAY DIFFRACTION / Resolution: 1.15 Å PDB-7fv4: PanDDA analysis group deposition -- PHIP in complex with Z44602341 Method: X-RAY DIFFRACTION / Resolution: 1.15 Å PDB-7fv5: PanDDA analysis group deposition -- PHIP in complex with Z606695272 Method: X-RAY DIFFRACTION / Resolution: 1.15 Å PDB-7fv6: PanDDA analysis group deposition -- PHIP in complex with Z1334218055 Method: X-RAY DIFFRACTION / Resolution: 1.19 Å PDB-7fv7: PanDDA analysis group deposition -- PHIP in complex with Z1929967066 Method: X-RAY DIFFRACTION / Resolution: 1.25 Å PDB-7fv8: PanDDA analysis group deposition -- PHIP in complex with Z964297186 Method: X-RAY DIFFRACTION / Resolution: 1.15 Å PDB-7fv9: PanDDA analysis group deposition -- PHIP in complex with Z1004253138 Method: X-RAY DIFFRACTION / Resolution: 1.17 Å PDB-7fva: PanDDA analysis group deposition -- PHIP in complex with Z4913872963 Method: X-RAY DIFFRACTION / Resolution: 1.19 Å PDB-7fvb: PanDDA analysis group deposition -- PHIP in complex with Z6617539657 Method: X-RAY DIFFRACTION / Resolution: 1.38 Å PDB-7fvc: PanDDA analysis group deposition -- PHIP in complex with Z495704106 Method: X-RAY DIFFRACTION / Resolution: 1.18 Å PDB-7fvd: PanDDA analysis group deposition -- PHIP in complex with Z1424453050 Method: X-RAY DIFFRACTION / Resolution: 1.36 Å PDB-7fve: PanDDA analysis group deposition -- PHIP in complex with Z488932160 Method: X-RAY DIFFRACTION / Resolution: 1.19 Å PDB-7fvf: PanDDA analysis group deposition -- PHIP in complex with Z123605878 Method: X-RAY DIFFRACTION / Resolution: 1.15 Å PDB-7fvg: PanDDA analysis group deposition -- PHIP in complex with Z992453336 Method: X-RAY DIFFRACTION / Resolution: 1.15 Å PDB-7fvh: PanDDA analysis group deposition -- PHIP in complex with Z5067911819 Method: X-RAY DIFFRACTION / Resolution: 1.15 Å PDB-7fvi: PanDDA analysis group deposition -- PHIP in complex with Z183306756 Method: X-RAY DIFFRACTION / Resolution: 1.18 Å PDB-7fvj: PanDDA analysis group deposition -- PHIP in complex with Z4913873236 Method: X-RAY DIFFRACTION / Resolution: 1.19 Å PDB-7fvk: PanDDA analysis group deposition -- PHIP in complex with Z409964562 Method: X-RAY DIFFRACTION / Resolution: 1.15 Å PDB-7fvl: PanDDA analysis group deposition -- PHIP in complex with Z4140355932 Method: X-RAY DIFFRACTION / Resolution: 1.15 Å PDB-7fvm: PanDDA analysis group deposition -- PHIP in complex with Z1590917771 Method: X-RAY DIFFRACTION / Resolution: 1.26 Å PDB-7fvn: PanDDA analysis group deposition -- PHIP in complex with Z371875396 Method: X-RAY DIFFRACTION / Resolution: 1.15 Å PDB-7fvo: PanDDA analysis group deposition -- PHIP in complex with Z1435810807 Method: X-RAY DIFFRACTION / Resolution: 1.19 Å PDB-7fvp: PanDDA analysis group deposition -- PHIP in complex with Z1004277578 Method: X-RAY DIFFRACTION / Resolution: 1.15 Å PDB-7fvq: PanDDA analysis group deposition -- PHIP in complex with Z68576046 Method: X-RAY DIFFRACTION / Resolution: 1.15 Å PDB-7fvr: PanDDA analysis group deposition -- PHIP in complex with Z166737374 Method: X-RAY DIFFRACTION / Resolution: 1.19 Å PDB-7g9k: PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z1262246195 Method: X-RAY DIFFRACTION / Resolution: 1.551 Å PDB-7g9l: PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z111782404 Method: X-RAY DIFFRACTION / Resolution: 1.541 Å PDB-7g9m: PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z44584886 Method: X-RAY DIFFRACTION / Resolution: 1.541 Å PDB-7g9n: PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z57821475 Method: X-RAY DIFFRACTION / Resolution: 1.422 Å PDB-7g9o: PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z133716556 Method: X-RAY DIFFRACTION / Resolution: 1.931 Å PDB-7g9p: PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z1619958679 Method: X-RAY DIFFRACTION / Resolution: 1.743 Å PDB-7g9q: PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z751811134 Method: X-RAY DIFFRACTION / Resolution: 2.131 Å PDB-7g9r: PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z385450668 Method: X-RAY DIFFRACTION / Resolution: 1.798 Å PDB-7g9s: PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z758198920 Method: X-RAY DIFFRACTION / Resolution: 2.09 Å PDB-7g9t: PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z18618496 Method: X-RAY DIFFRACTION / Resolution: 1.904 Å PDB-7g9u: PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z55222357 Method: X-RAY DIFFRACTION / Resolution: 1.689 Å PDB-7g9v: PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z383202616 Method: X-RAY DIFFRACTION / Resolution: 1.74 Å PDB-7g9w: PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z444860982 Method: X-RAY DIFFRACTION / Resolution: 1.855 Å PDB-7g9x: PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z905065822 Method: X-RAY DIFFRACTION / Resolution: 1.809 Å PDB-7g9y: PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z2678251369 Method: X-RAY DIFFRACTION / Resolution: 1.83 Å PDB-7g9z: PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z1216822028 Method: X-RAY DIFFRACTION / Resolution: 1.622 Å PDB-7ga0: PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z2048325751 Method: X-RAY DIFFRACTION / Resolution: 1.967 Å PDB-7ga1: PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with POB0128 Method: X-RAY DIFFRACTION / Resolution: 2.093 Å PDB-7ga2: PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with POB0008 Method: X-RAY DIFFRACTION / Resolution: 2.034 Å PDB-7ga3: PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z3241250482 Method: X-RAY DIFFRACTION / Resolution: 1.809 Å PDB-7ga4: PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z56823075 Method: X-RAY DIFFRACTION / Resolution: 1.749 Å PDB-7ga5: PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z119989094 Method: X-RAY DIFFRACTION / Resolution: 1.843 Å PDB-7ga6: PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z1509711879 Method: X-RAY DIFFRACTION / Resolution: 1.749 Å PDB-7ga7: PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z85933875 Method: X-RAY DIFFRACTION / Resolution: 1.42 Å PDB-7ga8: PanDDA analysis group deposition -- Crystal Structure of MAP1LC3B in complex with Z1198158918 Method: X-RAY DIFFRACTION / Resolution: 1.87 Å PDB-7ga9: PanDDA analysis group deposition -- Crystal Structure of MAP1LC3B in complex with Z1198177230 Method: X-RAY DIFFRACTION / Resolution: 2.17 Å PDB-7gaa: PanDDA analysis group deposition -- Crystal Structure of MAP1LC3B in complex with Z1198233191 Method: X-RAY DIFFRACTION / Resolution: 2.03 Å PDB-7gab: PanDDA analysis group deposition -- Crystal Structure of MAP1LC3B in complex with Z1255402624 Method: X-RAY DIFFRACTION / Resolution: 2.23 Å PDB-7gac: PanDDA analysis group deposition -- Crystal Structure of MAP1LC3B in complex with Z1456069604 Method: X-RAY DIFFRACTION / Resolution: 1.91 Å PDB-7gad: PanDDA analysis group deposition -- Crystal Structure of MAP1LC3B in complex with Z1667545918 Method: X-RAY DIFFRACTION / Resolution: 1.86 Å PDB-7gae: PanDDA analysis group deposition -- Crystal Structure of MAP1LC3B in complex with Z1688504114 Method: X-RAY DIFFRACTION / Resolution: 1.92 Å PDB-7gaf: PanDDA analysis group deposition -- Crystal Structure of MAP1LC3B in complex with Z183352334 Method: X-RAY DIFFRACTION / Resolution: 1.84 Å PDB-7gag: PanDDA analysis group deposition -- Crystal Structure of MAP1LC3B in complex with Z198195770 Method: X-RAY DIFFRACTION / Resolution: 1.59 Å PDB-7gah: PanDDA analysis group deposition -- Crystal Structure of MAP1LC3B in complex with Z2033637875 Method: X-RAY DIFFRACTION / Resolution: 1.9 Å PDB-7gai: PanDDA analysis group deposition -- Crystal Structure of MAP1LC3B in complex with Z212122838 Method: X-RAY DIFFRACTION / Resolution: 1.97 Å PDB-7gaj: PanDDA analysis group deposition -- Crystal Structure of MAP1LC3B in complex with Z285233820 Method: X-RAY DIFFRACTION / Resolution: 1.89 Å PDB-7gak: PanDDA analysis group deposition -- Crystal Structure of MAP1LC3B in complex with Z287121492 Method: X-RAY DIFFRACTION / Resolution: 1.77 Å PDB-7gal: PanDDA analysis group deposition -- Crystal Structure of MAP1LC3B in complex with Z291279160 Method: X-RAY DIFFRACTION / Resolution: 1.91 Å PDB-7gam: PanDDA analysis group deposition -- Crystal Structure of MAP1LC3B in complex with Z373768900 Method: X-RAY DIFFRACTION / Resolution: 1.75 Å PDB-7gan: PanDDA analysis group deposition -- Crystal Structure of MAP1LC3B in complex with Z56767614 Method: X-RAY DIFFRACTION / Resolution: 2.09 Å PDB-7gao: PanDDA analysis group deposition -- Crystal Structure of MAP1LC3B in complex with Z57450788 Method: X-RAY DIFFRACTION / Resolution: 1.69 Å PDB-7gap: PanDDA analysis group deposition -- Crystal Structure of MAP1LC3B in complex with Z728939702 Method: X-RAY DIFFRACTION / Resolution: 1.68 Å PDB-7gaq: PanDDA analysis group deposition -- Crystal Structure of MAP1LC3B in complex with Z755044716 Method: X-RAY DIFFRACTION / Resolution: 2.14 Å PDB-7gar: PanDDA analysis group deposition -- Crystal Structure of MAP1LC3B in complex with Z820676436 Method: X-RAY DIFFRACTION / Resolution: 2.07 Å PDB-7gas: PanDDA analysis group deposition -- Crystal Structure of MAP1LC3B in complex with Z952016136 Method: X-RAY DIFFRACTION / Resolution: 1.91 Å PDB-7hi8: PanDDA analysis group deposition -- Crystal Structure of ground state model of human Brachyury Method: X-RAY DIFFRACTION / Resolution: 1.54 Å
Chemicals	ChemComp-MLI: MALONATE ION ChemComp-NI: NICKEL (II) ION ChemComp-9KS: N-(2-hydroxyphenyl)acetamide ChemComp-HOH: WATER ChemComp-AW7: 2-[4-(1~{H}-pyrazol-3-yl)phenoxy]pyrimidine ChemComp-AWA: (6~{R})-6-(4-methoxyphenyl)-2-oxidanylidene-5,6-dihydro-1~{H}-pyrimidine-4-carboxylic acid ChemComp-AWD: ~{N}-(4-fluorophenyl)-4-methyl-piperazine-1-carboxamide ChemComp-AWG: ~{N}2-(1~{H}-benzimidazol-2-yl)benzene-1,2-diamine ChemComp-AWM: 2-(4-methylpiperazin-1-yl)-1,3-benzothiazole ChemComp-AWP: 1-cyclohexyl-3-(2-pyridin-4-ylethyl)urea ChemComp-AWS: 8-[(dimethylamino)methyl]-4-methyl-7-oxidanyl-chromen-2-one ChemComp-AWV: 3-(azepan-1-ylmethyl)-1~{H}-indole ChemComp-AWY: ~{N}-[2-(7-methoxynaphthalen-1-yl)ethyl]ethanamide / antidepressantYM ChemComp-AXG: 1-(phenylmethyl)-4-pyrrol-1-yl-piperidine ChemComp-AXJ: [(2~{R})-1-[[(1~{R},5~{S})-6,6-dimethyl-2-bicyclo[3.1.1]hept-2-enyl]methyl]pyrrolidin-2-yl]methanol ChemComp-AXS: 1-(4-fluorophenyl)-~{N}-[[(2~{R})-oxolan-2-yl]methyl]methanamine ChemComp-AXV: 1~{H}-benzimidazol-2-ylcyanamide ChemComp-AY4: 2,4-bis(fluoranyl)-6-(1~{H}-pyrazol-3-yl)phenol ChemComp-AYJ: 2-[cyclohexyl(methylsulfonyl)amino]ethanamide ChemComp-AYS: 2-[(4-chlorophenyl)amino]benzamide ChemComp-AYV: 1-[2-methyl-1,3-bis(oxidanyl)propan-2-yl]-3-phenyl-urea ChemComp-B0A: ~{N}-cyclohexyl-2-phenoxy-ethanamide ChemComp-B0G: (phenylmethyl) 4-oxidanylpiperidine-1-carboxylate ChemComp-B0J: 4-[[[(4~{S})-2,2-dimethyloxan-4-yl]amino]methyl]phenol ChemComp-B0M: 1~{H}-indol-6-yl-(4-methylpiperazin-1-yl)methanone ChemComp-B0V: 2-methoxy-~{N}-(2,4,6-trimethylphenyl)ethanamide ChemComp-DMS: DIMETHYL SULFOXIDE / DMSO, precipitantYM ChemComp-B0Y: 5-ethyl-~{N}-[(1-methylpyrazol-4-yl)methyl]thiophene-2-carboxamide ChemComp-B1A: ~{N}-(4-phenylazanylphenyl)ethanamide ChemComp-B1J: [1-(4-chlorophenyl)-1,2,3-triazol-4-yl]methanol ChemComp-ACT: ACETATE ION ChemComp-H3D: N-[1-(2,3-dihydro-1,4-benzodioxin-6-yl)cyclopentyl]acetamide ChemComp-CL: Unknown entry ChemComp-GQY: 2-methoxy-4-morpholin-4-yl-aniline ChemComp-GV1: ~{N},~{N},5,6-tetramethylthieno[2,3-d]pyrimidin-4-amine ChemComp-GV7: 4-[(5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)amino]phenol ChemComp-GVY: 4-(5-amino-1,3,4-thiadiazol-2-yl)phenol ChemComp-GW1: (4-chloranyl-2-methyl-pyrazol-3-yl)-piperidin-1-yl-methanone ChemComp-MG: Unknown entry ChemComp-K0G: N-phenyl-N'-pyridin-3-ylurea ChemComp-EDO: 1,2-ETHANEDIOL ChemComp-PEG: DI(HYDROXYETHYL)ETHER ChemComp-JGD: N,N-dimethylpyridin-4-amine ChemComp-LD4: N-cycloheptylpyrimidin-2-amine ChemComp-JG4: 2-(thiophen-2-yl)-1H-imidazole ChemComp-JGP: (azepan-1-yl)(2H-1,3-benzodioxol-5-yl)methanone ChemComp-LDV: 3-[(4-methylpiperidin-1-yl)methyl]-1H-indole ChemComp-LDS: N-(4-ethoxyphenyl)pyrazine-2-carboxamide ChemComp-LDJ: 2-methyl-N-{5-[(2S)-oxolan-2-yl]-1,3,4-thiadiazol-2(3H)-ylidene}propanamide ChemComp-LDD: (azepan-1-yl)(4-methoxyphenyl)methanone ChemComp-LD7: 3-ethyl-N-[(4-fluorophenyl)methyl]-1,2,4-oxadiazole-5-carboxamide ChemComp-LEY: N-[(4-fluorophenyl)methyl]-2-(propan-2-yl)-1H-imidazole-5-carboxamide ChemComp-LES: (3S)-N-(pyrimidin-2-yl)azepan-3-amine ChemComp-LEJ: 1-(difluoromethyl)-N-[(4-fluorophenyl)methyl]-1H-pyrazole-3-carboxamide ChemComp-LE7: N-[(4-fluorophenyl)methyl]-3-propyl-1H-pyrazole-5-carboxamide ChemComp-LE4: [2-(cycloheptylamino)pyrimidin-4-yl]methanol ChemComp-LFP: 5-chloro-N-[(4-fluorophenyl)methyl]-1-methyl-1H-pyrazole-4-carboxamide ChemComp-LFM: N-[(4-fluorophenyl)methyl]-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-3-carboxamide ChemComp-LFJ: 1-[4-(2H-1,3-benzodioxole-5-carbonyl)-2,3,4,5-tetrahydro-1H-1,4-diazepin-1-yl]ethan-1-one ChemComp-LFG: N-cycloheptyl-5-cyclopropyl-1,3,4-oxadiazol-2-amine ChemComp-LF4: N-[(4-fluorophenyl)methyl]-3-(propan-2-yl)-1H-pyrazole-5-carboxamide ChemComp-LJ7: N-[(4-fluorophenyl)methyl]-1-(propan-2-yl)-1H-pyrazole-3-carboxamide ChemComp-LHS: N-[(4-fluorophenyl)methyl]-5-(methoxymethyl)-1,2,4-oxadiazole-3-carboxamide ChemComp-LHM: N-[(4-fluorophenyl)methyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine-3-carboxamide ChemComp-LH7: 1-[(3S)-1,1-dioxo-1lambda~6~-thiolan-3-yl]-N-[(4-fluorophenyl)methyl]-5-methyl-1H-pyrazole-4-carboxamide ChemComp-LFY: 1-ethyl-N-[(4-fluorophenyl)methyl]-1H-imidazole-4-carboxamide ChemComp-LJM: 5-ethyl-N-[(4-fluorophenyl)methyl]-1,3-thiazole-2-carboxamide ChemComp-LJJ: N-cycloheptyl-5-methyl-1,3,4-oxadiazol-2-amine ChemComp-LJD: N-[(4-chlorophenyl)methyl]-1-methyl-1H-pyrazole-4-carboxamide ChemComp-JH1: 1-ethyl-N-[(4-fluorophenyl)methyl]-1H-pyrazole-4-carboxamide ChemComp-LJA: N-[3-(carbamoylamino)phenyl]acetamide ChemComp-JGA: N-ethyl-N'-(5-methyl-1,2-oxazol-3-yl)urea ChemComp-N5S: N-(5-methyl-1,2-oxazol-3-yl)-N'-[(3S)-4,4,4-trifluoro-3-hydroxy-3-(5-methylfuran-2-yl)butyl]urea ChemComp-N5V: N-ethyl-N'-1,3-thiazol-2-ylurea ChemComp-N64: N-(5-methyl-1,2-oxazol-3-yl)-N'-[3-(4-phenylpiperazin-1-yl)propyl]urea ChemComp-N67: N-methyl-5-({[(5-methyl-1,2-oxazol-3-yl)carbamoyl]amino}methyl)thiophene-2-sulfonamide ChemComp-N6D: N-[3-(methoxymethyl)phenyl]-N'-(5-methyl-1,2-oxazol-3-yl)urea ChemComp-N6J: N-{1-[(imidazo[1,2-a]pyridin-2-yl)methyl]-1H-pyrazol-4-yl}-N'-(5-methyl-1,2-oxazol-3-yl)urea ChemComp-N6V: N-{1-[2-(diethylamino)ethyl]-1H-indol-5-yl}-N'-(5-methyl-1,2-oxazol-3-yl)urea ChemComp-N71: N-(5-methyl-1,2-oxazol-3-yl)-N'-[2-(phenylsulfonyl)ethyl]urea ChemComp-N74: N-(1-benzyl-1H-pyrazol-4-yl)-N'-(5-methyl-1,2-oxazol-3-yl)urea ChemComp-N5D: N-cyclopropyl-2-(4-{[(5-methyl-1,2-oxazol-3-yl)carbamoyl]amino}-1H-pyrazol-1-yl)acetamide ChemComp-PLP: PYRIDOXAL-5'-PHOSPHATE ChemComp-NSJ: 3-[(thiomorpholin-4-yl)methyl]phenol ChemComp-NSV: 1-[(2-methyl-1,3-thiazol-5-yl)methyl]piperazine ChemComp-JHP: 4-chloro-N-cyclopentyl-1-methyl-1H-pyrazole-3-carboxamide ChemComp-NT7: N-(2,3-dimethylphenyl)-2-(morpholin-4-yl)acetamide ChemComp-NTG: 5-(1,4-oxazepan-4-yl)pyridine-2-carbonitrile ChemComp-NTV: (2S)-N-(3-chloro-2-methylphenyl)oxolane-2-carboxamide ChemComp-NU4: 2-methyl-N-(pyridin-4-yl)furan-3-carboxamide ChemComp-NUA: N-(1-ethyl-1H-pyrazol-4-yl)cyclobutanecarboxamide ChemComp-NUG: 1-[(2,5-dihydrothiophen-3-yl)methyl]piperidin-4-ol ChemComp-NUJ: trans-3-[(2,6-dimethylpyrimidin-4-yl)(methyl)amino]cyclobutan-1-ol ChemComp-NUM: N-[2-(4-hydroxyphenyl)ethyl]pyridine-2-carboxamide ChemComp-HR5: ~{N}-(cyclobutylmethyl)-1,5-dimethyl-pyrazole-4-carboxamide ChemComp-JO1: 1-methyl-N-[(thiophen-2-yl)methyl]-1H-pyrazole-5-carboxamide ChemComp-NUY: [4-(propan-2-yl)piperazin-1-yl](thiophen-2-yl)methanone ChemComp-NV7: 1-[(furan-2-yl)methyl]-4-(methylsulfonyl)piperazine ChemComp-K0V: methyl 1-(tert-butylcarbamoyl)piperidine-4-carboxylate ChemComp-LUY: ~{N}-(2-phenylethyl)-1~{H}-benzimidazol-2-amine ChemComp-NVD: N-{[4-(dimethylamino)phenyl]methyl}-4H-1,2,4-triazol-4-amine ChemComp-NVJ: ethyl benzylcarbamate ChemComp-NVM: [(4R)-4-methyl-2,3,4,5-tetrahydro-1H-azepin-1-yl](1,3-thiazol-4-yl)methanone ChemComp-NVY: 1-ethyl-N-(2-fluorophenyl)piperidin-4-amine ChemComp-NW4: 3-cyclohexyl-1-(morpholin-4-yl)propan-1-one ChemComp-J4Q: 4-[(2-methylsulfonylimidazol-1-yl)methyl]-1,3-thiazole ChemComp-NW7: 3-ethyl-5-methyl-N-(5-methyl-1,2-oxazol-3-yl)-1,2-oxazole-4-carboxamide ChemComp-CD: Unknown entry ChemComp-JMM: [4-(cyclopropanecarbonyl)piperazin-1-yl](furan-2-yl)methanone ChemComp-NWP: (2R)-N,2-dimethyl-N-(propan-2-yl)morpholine-4-sulfonamide ChemComp-NWV: N-[(1-methyl-1H-pyrazol-4-yl)methyl]furan-2-carboxamide ChemComp-NWY: N-[(6-methylpyridin-3-yl)methyl]cyclobutanecarboxamide ChemComp-K1A: 3-[(3,5-dimethyl-1,2-oxazol-4-yl)methyl]-5-methyl-1,3,4-thiadiazol-2(3H)-one ChemComp-NX7: (2,6-difluorophenyl)(pyrrolidin-1-yl)methanone ChemComp-NXJ: (1S)-N,2,2-trimethyl-N-(pyridin-3-yl)cyclopropane-1-carboxamide ChemComp-NXM: 4-[(3-cyclopropyl-1,2,4-oxadiazol-5-yl)methyl]piperidine ChemComp-NXS: [1-(pyrimidin-2-yl)piperidin-4-yl]methanol ChemComp-NY1: 2-(2-methyl-1,3-thiazol-4-yl)-1-(morpholin-4-yl)ethan-1-one ChemComp-NY4: N-{4-[(1S)-1-aminoethyl]phenyl}cyclopropanecarboxamide ChemComp-GWA: ~{N}-(3-acetamidophenyl)-2-methoxy-ethanamide ChemComp-NY7: N-(2-methoxy-5-methylphenyl)glycinamide ChemComp-K2M: 4-(furan-2-carbonyl)piperazine-1-carboxamide ChemComp-NYV: 1-(propan-2-yl)-1H-imidazole-4-sulfonamide ChemComp-NZG: 3-(acetylamino)-4-fluorobenzoic acid ChemComp-NZD: 4-methyl-N-phenylpiperazine-1-carboxamide ChemComp-NZ7: (5R)-N,N-dimethyl-2,9-dioxa-6-azaspiro[4.5]decane-6-carboxamide ChemComp-NZ4: N-(3-acetylphenyl)morpholine-4-carboxamide ChemComp-NZ1: 5-methoxy-1,3-benzothiazol-2-amine ChemComp-LV4: 1-[2-(trifluoromethyloxy)phenyl]thiourea ChemComp-JFP: N-(4-methyl-1,3-thiazol-2-yl)propanamide ChemComp-NZJ: 1-(3-methylbenzene-1-carbonyl)piperidine-4-carboxamide ChemComp-O0G: (2S)-2-[(5-chloro-3-fluoropyridin-2-yl)amino]propan-1-ol ChemComp-O0J: N-[4-(2-amino-1,3-thiazol-4-yl)phenyl]acetamide ChemComp-K2P: 2-(trifluoromethoxy)benzoic acid ChemComp-O0M: 1-{[4-(propan-2-yl)phenyl]methyl}piperidin-4-ol ChemComp-O0P: N-[(3-fluorophenyl)methyl]-N-methylsulfuric diamide ChemComp-O0S: N-{4-[(pyrimidin-2-yl)oxy]phenyl}acetamide ChemComp-O0V: (2S)-2-[(3-fluoropyridin-2-yl)(methyl)amino]propan-1-ol ChemComp-O0Y: 3-(diethylamino)phenol ChemComp-O1A: N-[4-(4-methylpiperazin-1-yl)phenyl]acetamide ChemComp-O1D: 3-(benzyloxy)aniline ChemComp-O1M: 4-(4-fluorophenyl)piperazine-1-carboxamide ChemComp-O1J: (benzyloxy)acetic acid ChemComp-O2A: N-methyl-1H-indole-7-carboxamide ChemComp-O2D: 2-cyclohexyl-N-(4H-1,2,4-triazol-4-yl)acetamide ChemComp-O2J: (2R)-2-(methoxymethyl)-4-(pyridin-2-yl)morpholine ChemComp-O2M: N-[(4-methyl-1,3-thiazol-2-yl)methyl]-1H-pyrazole-5-carboxamide ChemComp-LVV: 4-[(4-methylphenyl)methyl]-1,4-thiazinane 1,1-dioxide ChemComp-O2P: N-(2-hydroxy-4-methylphenyl)-2-methylbenzamide ChemComp-O3A: (3S)-N-methyl-N-phenylpyrrolidine-3-carboxamide ChemComp-O3D: 4-[(furan-2-yl)methyl]-1lambda~6~,4-thiazinane-1,1-dione ChemComp-O3G: N-benzyl-1-(4-fluorophenyl)methanamine ChemComp-O3J: 1-[4-(3-phenylpropyl)piperazin-1-yl]ethan-1-one ChemComp-O3M: 4-[(3,4-dihydroisoquinolin-2(1H)-yl)methyl]phenol ChemComp-K0J: N-ethyl-1H-1,2,3-triazole-4-carboxamide ChemComp-K3J: N-ethyl-6-methylpyridazin-3-amine ChemComp-JHJ: N-(4-methoxyphenyl)-N'-pyridin-4-ylurea ChemComp-DSJ: 1-(4-amino-2-hydroxyphenyl)ethan-1-one ChemComp-UNX: Unknown entry ChemComp-SO4: SULFATE ION ChemComp-PW7: 4-(trifluoromethyl)pyrimidin-2-amine ChemComp-PWA: 7-fluoroquinazolin-4(3H)-one ChemComp-PWD: 5-fluoro-1H-pyrrolo[2,3-b]pyridine ChemComp-PWG: 3-(difluoromethyl)-8-(trifluoromethyl)[1,2,4]triazolo[4,3-a]pyridine ChemComp-PWJ: 8-chloro-6-(trifluoromethyl)imidazo[1,2-a]pyridine-7-carbonitrile ChemComp-PWM: 5-fluoroquinazolin-4(3H)-one ChemComp-PWP: 6-fluoroquinazolin-4(3H)-one ChemComp-PWS: 3-methyl-2-(methylsulfanyl)-6-(trifluoromethyl)pyrimidin-4(3H)-one ChemComp-RU4: 4-(1,2,3-thiadiazol-4-yl)phenyl ethylcarbamate ChemComp-TRS: 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL / pH bufferYM ChemComp-HWH: ~{N}-[2-(5-fluoranyl-1~{H}-indol-3-yl)ethyl]ethanamide ChemComp-RUV: 4-(acetylamino)-N-(4H-1,2,4-triazol-4-yl)benzamide ChemComp-RUY: 4-(piperidin-1-yl)-1,2,5-oxadiazol-3-amine ChemComp-RV4: N-{4-[(morpholin-4-yl)methyl]phenyl}acetamide ChemComp-M25: N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE ChemComp-K3D: 4-acetyl-N-ethylpiperazine-1-carboxamide ChemComp-ZN: Unknown entry ChemComp-RVY: (5S)-5-methyl-5-[(1-phenyl-1H-1,2,3-triazol-4-yl)methyl]pyrrolidine-2,4-dione ChemComp-RW7: (3S)-3,4-dimethyl-3-propyl-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione ChemComp-RWA: (5R)-3,3,5-trimethyl-5-[(1-phenyl-1H-1,2,3-triazol-4-yl)methyl]pyrrolidine-2,4-dione ChemComp-RWD: (4S,5R)-4-hydroxy-5-methyl-5-[(1-phenyl-1H-1,2,3-triazol-4-yl)methyl]pyrrolidin-2-one ChemComp-RWG: (5R)-5-{[1-(4-fluorophenyl)-1H-1,2,3-triazol-4-yl]methyl}-5-methylpyrrolidine-2,4-dione ChemComp-RWM: (5S)-5-methyl-5-[(3-phenyl-1,2-oxazol-5-yl)methyl]pyrrolidine-2,4-dione ChemComp-RY4: N-[4-(aminomethyl)phenyl]methanesulfonamide ChemComp-GQJ: methyl (2~{S},4~{R})-1-(furan-2-ylcarbonyl)-4-oxidanyl-pyrrolidine-2-carboxylate ChemComp-RYG: ~{N}-[(3~{R})-2-oxidanylideneazepan-3-yl]furan-2-carboxamide ChemComp-RYM: 4-(benzimidazol-1-ylmethyl)benzenecarbonitrile ChemComp-RYP: ~{N}-methyl-1-pyridin-4-yl-methanamine ChemComp-S07: 2-(2,4-dimethylphenoxy)-1-morpholin-4-yl-ethanone ChemComp-S0P: ~{N}-(4-cyanophenyl)ethanamide ChemComp-S0S: (3~{R},4~{R})-1,1-bis(oxidanylidene)-4-(pyridin-3-ylmethylamino)thiolan-3-ol ChemComp-6SU: methyl 3-(methylsulfonylamino)benzoate ChemComp-S0V: morpholin-4-yl(1,2,3-thiadiazol-4-yl)methanone ChemComp-S1G: 4-[(phenylmethyl)amino]benzoic acid ChemComp-GQP: 1-[(4-fluorophenyl)methyl]benzimidazole ChemComp-S1J: 3-azanyl-4-(pyridin-3-ylmethylamino)benzoic acid ChemComp-N08: ~{N}-[2-(4-fluorophenyl)ethyl]furan-2-carboxamide ChemComp-S1M: methyl 2-[(2~{S})-1-ethanoyl-3-oxidanylidene-piperazin-2-yl]ethanoate ChemComp-JOV: 3-chloro-N-(1-hydroxy-2-methylpropan-2-yl)benzamide ChemComp-S1V: 1-ethanoylpiperidine-4-carbonitrile ChemComp-MH5: 3-[(5-methylthiophen-2-yl)methylamino]benzoic acid ChemComp-S2J: methyl 2-[(2~{R})-1-(ethylcarbamoyl)-3-oxidanylidene-piperazin-2-yl]ethanoate ChemComp-S2S: 4-(methylsulfonylamino)benzamide ChemComp-S2V: (1-methylpiperidin-4-yl) 3-fluoranylbenzoate ChemComp-V3J: (4,7-dihydro-2H-1lambda~4~,2,3-benzothiadiazol-5-yl)(morpholin-4-yl)methanone ChemComp-S2Y: ~{N}-[(4-fluorophenyl)methyl]-4-methoxy-aniline ChemComp-7MU: 4-chloranyl-~{N}-methyl-pyridine-2-carboxamide ChemComp-S34: 2-cyano-~{N}-(pyridin-4-ylmethyl)ethanamide ChemComp-RWS: 1-(5-methyl-1,3,4-thiadiazol-2-yl)piperidine ChemComp-EJQ: ~{N}-(4-fluorophenyl)-2-pyrrolidin-1-yl-ethanamide ChemComp-RWV: 1-{1-[(2-methyl-1,3-thiazol-4-yl)methyl]piperidin-4-yl}methanamine ChemComp-JGG: N-[(4-cyanophenyl)methyl]morpholine-4-carboxamide ChemComp-RX7: 2-methyl-2-{[(3-methylthiophen-2-yl)methyl]amino}propan-1-ol ChemComp-RXG: 2-(4-fluorophenoxy)-1-(1H-pyrrol-1-yl)ethan-1-one ChemComp-K1P: 1-(3-methyl-1,2,4-thiadiazol-5-yl)-1,4-diazepane ChemComp-RXJ: 4-(4-methylpiperazin-1-yl)benzonitrile ChemComp-RXS: 3-[(2-methyl-1H-imidazol-1-yl)methyl]benzonitrile ChemComp-M0J: N-[(2S)-2-hydroxypropyl]-N'-phenylurea ChemComp-K0Y: methyl N-(5-methyl-1,2-oxazole-3-carbonyl)glycinate ChemComp-S6V: 1-[2-(2-oxidanylidenepyrrolidin-1-yl)ethyl]-3-phenyl-urea ChemComp-PO4: PHOSPHATE ION ChemComp-MPD: (4S)-2-METHYL-2,4-PENTANEDIOL / precipitantYM ChemComp-UQJ: 3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide ChemComp-T6J: 2-[(methylsulfonyl)methyl]-1H-benzimidazole ChemComp-UQM: N-[4-(2-amino-2-oxoethyl)phenyl]acetamide ChemComp-H04: 1-(2-ethoxyphenyl)piperazine ChemComp-UQS: N-[(2-fluorophenyl)methyl]-1H-pyrazol-4-amine ChemComp-UQV: [2-(acetylamino)phenyl]acetic acid ChemComp-7ZC: 1-(5-methoxy-1H-indol-3-yl)-N,N-dimethyl-methanamine ChemComp-JFS: [4-(1H-benzimidazol-1-yl)phenyl]methanol ChemComp-UQY: 1-(methylamino)cyclopentane-1-carboxamide ChemComp-UR7: 1-(3-fluoro-4-methylphenyl)methanesulfonamide ChemComp-UR4: 2-methoxy-N-(4-phenyl-1,3-thiazol-2-yl)acetamide ChemComp-UR1: 3-fluoro-5-methylbenzene-1-sulfonamide ChemComp-TPP: THIAMINE DIPHOSPHATE ChemComp-T1J: 2-{[(1H-benzimidazol-2-yl)amino]methyl}phenol ChemComp-WGA: (3S)-1-(3-fluoropyridin-2-yl)-4,4-dimethylpyrrolidin-3-ol ChemComp-WGD: 1-{(2S,4S)-4-fluoro-1-[(2-methyl-1,3-thiazol-4-yl)methyl]pyrrolidin-2-yl}methanamine ChemComp-2L1: 2-[(4-methyl-1H-imidazol-5-yl)methyl]-1,2,3,4-tetrahydroisoquinoline ChemComp-U0M: 5-fluoro-1-[(5-methyl-1,3,4-thiadiazol-2-yl)methyl]-1,2,3,6-tetrahydropyridine ChemComp-I81: 1-[(3-methoxyphenyl)methyl]piperidine-4-carboxamide ChemComp-I87: (2S)-N,2-dimethyl-N-(propan-2-yl)morpholine-4-sulfonamide ChemComp-I8A: N-(cyclopropylmethyl)-2,2,3,3-tetramethylazetidine-1-carboxamide ChemComp-I8D: (4-chlorophenyl)(thiomorpholin-4-yl)methanone ChemComp-I8G: 2-(4-fluorophenoxy)-1-(pyrrolidin-1-yl)ethan-1-one ChemComp-I8J: 5-fluoro-1-(1-methylcyclopropane-1-sulfonyl)-1,2,3,6-tetrahydropyridine ChemComp-I8M: 2-[(morpholin-4-yl)methyl]phenol ChemComp-LF6: {(1R,2R)-2-[(Z)-(3-methyl-1,2,4-thiadiazol-5(2H)-ylidene)amino]cyclopentyl}methanol ChemComp-LFO: N,1-dimethyl-1H-indole-3-carboxamide ChemComp-LGR: 2-[acetyl(methyl)amino]benzoic acid ChemComp-LHR: N-(1H-indazol-6-yl)acetamide ChemComp-WNV: N,N,2,3-tetramethylbenzamide ChemComp-60P: 3-methylthiophene-2-carboxylic acid ChemComp-W0G: (3R)-1-(2-fluorophenyl)-3-(methylamino)pyrrolidin-2-one ChemComp-LJR: 1-cyclohexyl-N-methylmethanesulfonamide ChemComp-LJK: 3-methyl-N-(2-methylbutan-2-yl)-1H-pyrazole-5-carboxamide ChemComp-U1V: 1-(4-fluoro-2-methylphenyl)methanesulfonamide ChemComp-LJ6: (2R)-3-(3,5-dimethyl-1,2-oxazol-4-yl)-N,N,2-trimethylpropanamide ChemComp-LLU: (2S)-2-(2-fluorophenoxy)propanoic acid ChemComp-LL0: 2-(difluoromethoxy)benzene-1-sulfonamide ChemComp-LKU: 3-fluoro-N-(3-hydroxy-4-methylphenyl)benzamide ChemComp-LKL: 2-[(5-chloro-3-fluoropyridin-2-yl)(methyl)amino]ethan-1-ol ChemComp-LK6: N-[(3R)-3-methyl-1,1-dioxo-1lambda~6~-thiolan-3-yl]cyclopropanecarboxamide ChemComp-WN1: N-(2-fluorophenyl)-3-methoxybenzamide ChemComp-JJM: 1-methyl-N-(3-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine ChemComp-UWY: N-(1-ethyl-1H-pyrazol-4-yl)cyclopentanecarboxamide ChemComp-ELQ: [3,4-bis(fluoranyl)phenyl]-(4-methylpiperazin-1-yl)methanone ChemComp-LO6: 2-(difluoromethoxy)-1-[(2R,6S)-2,6-dimethylmorpholin-4-yl]ethan-1-one ChemComp-SZE: 4-(3-fluoranylpyridin-2-yl)-1-methyl-piperazin-2-one ChemComp-LNS: 6-(methylcarbamoyl)pyridine-2-carboxylic acid ChemComp-UX1: 1-[(2-fluorophenyl)methyl]-N-methylcyclopropane-1-carboxamide ChemComp-U0V: 2-fluoro-N-[2-(pyridin-4-yl)ethyl]benzamide ChemComp-LMW: 2-[(4-aminophenyl)(ethyl)amino]ethan-1-ol ChemComp-LM6: 1-(1-ethyl-1H-pyrazol-5-yl)-N-methylmethanamine ChemComp-LQP: 2-(difluoromethoxy)-1-[(3aR,6aS)-hexahydrocyclopenta[c]pyrrol-2(1H)-yl]ethan-1-one ChemComp-LQI: (1-benzofuran-2-yl)(4-methylpiperidin-1-yl)methanone ChemComp-WH1: N-methyl-N-[2-(pyridin-2-yl)ethyl]benzamide ChemComp-LQ3: (5S)-5-(difluoromethoxy)pyridin-2(5H)-one ChemComp-GT4: ~{N}-(4-hydroxyphenyl)-2-methoxy-ethanamide ChemComp-S5J: 2-[4-(2-methoxyphenyl)piperazin-1-yl]ethanenitrile ChemComp-LPU: 1-(methanesulfonyl)piperidin-4-ol ChemComp-WKA: N-(2,1,3-benzoxadiazol-4-yl)acetamide ChemComp-VZS: N-(2-methoxy-5-methylphenyl)-N'-4H-1,2,4-triazol-4-ylurea ChemComp-LRR: 1-(morpholin-4-yl)-4-phenylbutan-1-one ChemComp-LRF: N~2~-(4-cyano-3-methyl-1,2-thiazol-5-yl)-N~2~-methylglycinamide ChemComp-WKS: 2,4-dimethyl-6-(piperazin-1-yl)pyrimidine ChemComp-K1S: N,N-diethyl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine / antagonistYM ChemComp-LR9: 3-amino-N-ethyl-N-methylbenzamide ChemComp-LQV: (2S)-N-(5-methylpyridin-2-yl)oxolane-2-carboxamide ChemComp-ZIM: N-(2-chlorophenyl)-4-(furan-2-carbonyl)piperazine-1-carboxamide ChemComp-ZJ8: 4-(furan-2-carbonyl)-N-propylpiperazine-1-carboxamide ChemComp-ZJE: N-{[(2S)-oxolan-2-yl]methyl}-4-(thiophene-2-carbonyl)piperazine-1-carboxamide ChemComp-ZJI: N-cyclopropyl-4-(furan-2-carbonyl)piperazine-1-carboxamide ChemComp-ZJN: (3S)-2-benzyl-N'-[4-(furan-2-carbonyl)piperazine-1-carbonyl]-1,2,3,4-tetrahydroisoquinoline-3-carbohydrazide ChemComp-ZJR: 4-(furan-2-carbonyl)-N-(prop-2-yn-1-yl)piperazine-1-carboxamide ChemComp-ZJW: N-[2-(3-ethyl-4H-1,2,4-triazol-4-yl)ethyl]-4-(5-methylthiophene-2-carbonyl)piperazine-1-carboxamide ChemComp-ZK0: N-tert-butyl-4-(2,3,3-trimethyl-3H-indole-5-carbonyl)piperazine-1-carboxamide ChemComp-ZK6: 4-(furan-2-carbonyl)-N-phenylpiperazine-1-carboxamide ChemComp-ZKC: tert-butyl [3-({[4-(furan-2-carbonyl)piperazine-1-carbonyl]amino}methyl)phenyl]carbamate ChemComp-ZKH: N-(2-methoxyethyl)-4-(thiophene-2-carbonyl)piperazine-1-carboxamide ChemComp-ZKL: (2R)-N-butyl-4-(furan-2-carbonyl)-2-methylpiperazine-1-carboxamide ChemComp-ZKQ: N-(2-fluorophenyl)-4-(furan-2-carbonyl)piperazine-1-carboxamide ChemComp-ZKU: 4-(furan-2-carbonyl)-N-(pyridin-2-yl)piperazine-1-carboxamide ChemComp-ZKZ: N-methyl-4-[5-(phenoxymethyl)furan-2-carbonyl]piperazine-1-carboxamide ChemComp-ZL3: (3R)-4-(furan-2-carbonyl)-3-methyl-N-(propan-2-yl)piperazine-1-carboxamide ChemComp-ZL8: 4-(3-chlorobenzoyl)-N-[3-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)-3-oxopropyl]-1,4-diazepane-1-carboxamide ChemComp-ZLC: 4-(5-methylfuran-2-carbonyl)-N-[(thiophen-2-yl)methyl]piperazine-1-carboxamide ChemComp-ZLH: (2S)-N-(cyclopropylmethyl)-4-(furan-2-carbonyl)-2-methylpiperazine-1-carboxamide ChemComp-ZLW: N-(2-aminoethyl)-4-(furan-2-carbonyl)piperazine-1-carboxamide ChemComp-ZM6: N-(cyclopropylmethyl)-4-(3,4-dichlorobenzoyl)piperazine-1-carboxamide ChemComp-ZM0: 4-(thieno[3,2-b]thiophene-2-carbonyl)-N-[(2S)-2,3,3-trimethylbutyl]piperazine-1-carboxamide ChemComp-ZMN: 4-(5-bromofuran-2-carbonyl)-N-[3-(3-methylphenoxy)propyl]piperazine-1-carboxamide ChemComp-ZMW: N-benzyl-4-(furan-2-carbonyl)piperazine-1-carboxamide ChemComp-ZNX: N-(4-methoxyphenyl)-4-(5-methylfuran-2-carbonyl)piperazine-1-carboxamide ChemComp-ZOH: (2R)-4-(furan-3-carbonyl)-N-(4-methoxyphenyl)-2-methylpiperazine-1-carboxamide ChemComp-ZO5: N-[(2H-1,3-benzodioxol-5-yl)methyl]-4-(furan-2-carbonyl)piperazine-1-carboxamide ChemComp-ZOK: (2S)-4-(furan-2-carbonyl)-2-methyl-N-(2,2,2-trifluoroethyl)piperazine-1-carboxamide ChemComp-ZOU: 4-(furan-2-carbonyl)-N-(2-methoxy-5-methylphenyl)piperazine-1-carboxamide ChemComp-ZP0: N-{[(2S)-5,5-dimethyl-1,4-dioxan-2-yl]methyl}-4-(3-hydroxybenzoyl)piperazine-1-carboxamide ChemComp-ZP5: 4-(furan-2-carbonyl)-N-(1,2-oxazol-3-yl)piperazine-1-carboxamide ChemComp-ZPB: N-(propan-2-yl)-4-(thiophene-2-carbonyl)piperazine-1-carboxamide ChemComp-ZPL: N-[2-(4,5-dimethyl-1,3-thiazol-2-yl)ethyl]-4-(thiophene-2-carbonyl)piperazine-1-carboxamide ChemComp-ZQ0: N-butyl-4-(5-methylfuran-2-carbonyl)piperazine-1-carboxamide ChemComp-ZQ5: N-butyl-4-(thiophene-2-carbonyl)piperazine-1-carboxamide ChemComp-ZQ9: 4-(thiophene-2-carbonyl)-N-[(thiophen-2-yl)methyl]piperazine-1-carboxamide ChemComp-S7A: 3,3,3-tris(fluoranyl)-1-piperazin-1-yl-propan-1-one ChemComp-ZTQ: (2S)-2-[([1,1'-biphenyl]-4-yl)oxy]propanoic acid ChemComp-ZU7: N-(4-fluorophenyl)-2-(piperazin-1-yl)acetamide ChemComp-Z3H: N-[(4R)-3,4-dihydro-2H-1-benzopyran-4-yl]methanesulfonamide ChemComp-ZUC: 3-fluoro-N-(2-hydroxy-6-methylphenyl)pyridine-4-carboxamide ChemComp-ZUG: N,N-dimethylpyridine-3-sulfonamide ChemComp-ZUW: 1-(2,3-dihydro-1,4-benzoxazepin-4(5H)-yl)ethan-1-one ChemComp-ZUZ: methyl N-(cyclohexanecarbonyl)glycinate ChemComp-ZV2: 2-(2-azanyl-1,3-thiazol-3-yl)-~{N}-(4-fluorophenyl)ethanamide ChemComp-8C2: N-[(3,5-dimethyl-1H-pyrazol-4-yl)methyl]cyclohexanamine ChemComp-ZV5: (5R)-1,3,7-triazaspiro[4.5]decane-2,4-dione ChemComp-ZV8: 2-tert-butyl-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine ChemComp-ZVB: 2-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridine ChemComp-ZVE: (3R)-3-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl]piperidine ChemComp-ZVH: (1S,2R)-2-(thiophen-3-yl)cyclopentane-1-carboxylic acid ChemComp-YEK: methyl 1-(methanesulfonyl)-2-methyl-D-prolinate ChemComp-HV2: 1,1-bis(oxidanylidene)thietan-3-ol ChemComp-ZVK: ethyl N'-(4-ethylphenyl)-N-methylcarbamimidothioate ChemComp-ZVN: 2-(piperazin-1-yl)-1,3-benzothiazole ChemComp-YFR: 6-bromo-7-hydroxy-2,2-dimethyl-2H,4H-1,3-benzodioxin-4-one ChemComp-ZW5: 1-[(3-fluoro-4-methoxyphenyl)methyl]piperazine ChemComp, No image ChemComp-K4R: Unknown entry ChemComp, No image ChemComp-K6U: Unknown entry ChemComp-K7L: (4S)-imidazo[1,2-a]pyrimidine-5,7-diol ChemComp-EYK: 2-tert-butylbenzene-1,4-diol ChemComp, No image ChemComp-KF8: Unknown entry ChemComp, No image ChemComp-K8L: Unknown entry ChemComp-GV4: 2-cyano-~{N}-(1,3,5-trimethylpyrazol-4-yl)ethanamide ChemComp, No image ChemComp-K96: Unknown entry ChemComp, No image ChemComp-K9N: Unknown entry ChemComp, No image ChemComp-KB3: Unknown entry ChemComp, No image ChemComp-KA3: Unknown entry ChemComp-RWP: methyl 4-[(trifluoroacetyl)amino]benzoate ChemComp, No image ChemComp-KCC: Unknown entry ChemComp-2NU: 2-(4-bromanylpyrazol-1-yl)-~{N}-cyclopropyl-~{N}-methyl-ethanamide ChemComp, No image ChemComp-KBU*: Unknown entry
Source	homo sapiens (human) zika virus porphyromonas gingivalis (bacteria) severe acute respiratory syndrome coronavirus 2
Keywords	CELL CYCLE / SGC - Diamond I04-1 fragment screening / PanDDA / XChemExplorer / HYDROLASE / NUDIX domain / TRANSFERASE / macrodomain / NUDT5 / Hydrolase/Transferase / Hydrolase-Transferase complex / TRANSCRIPTION / BROMODOMAIN / BPTF / FALZ / FAC1 / BROMODOMAIN AND PHD FINGER-CONTAINING TRANSCRIPTION FACTOR / FETAL ALZ-50 CLONE 1 PROTEIN / RNA BINDING PROTEIN / CPSF5 / RNA PROCESSING / CLEAVAGE FACTOR / MRNA PROCESSING / NUCLEUS / PHOSPHOPROTEIN / RNA-BINDING / NUCLEOSIDE DIPHOSPHATE-LINKED MOIETY X MOTIF 22 / IMMUNE SYSTEM / FIBRINOGEN-RELATED PROTEIN (FREP) / PRO-INFLAMMATORY / DAMAGE-ASSOCIATED MOLECULAR PATTERN (DAMP) / VIRAL PROTEIN / OXIDOREDUCTASE / Diamond I04-1 fragment screening / peptidase / Porphyromonas gingivalis / HYDROLASE/HYDROLASE INHIBITOR / HYDROLASE-HYDROLASE INHIBITOR complex / SIGNALING PROTEIN / False negatives / ligand features / rescreening / catalogue / fragment follow-ups / automated chemistry / STRUCTURAL PROTEIN

+
About Yorodumi Papers

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

Version 3 of the EMDB header file is now the official format.
The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

+
Jul 12, 2017. Major update of PDB

-
Yorodumi Papers

Database of articles cited by EMDB/PDB/SASBDB data

Database of articles cited by EMDB, PDB, and SASBDB entries
Using PubMed data

Related info.:EMDB / PDB / SASBDB / Yorodumi / EMN Papers / Changes in new EM Navigator and Yorodumi